<SEC-DOCUMENT>0001069530-22-000056.txt : 20221103
<SEC-HEADER>0001069530-22-000056.hdr.sgml : 20221103
<ACCEPTANCE-DATETIME>20221103092607
ACCESSION NUMBER:		0001069530-22-000056
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20221103
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20221103
DATE AS OF CHANGE:		20221103

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CASSAVA SCIENCES INC
		CENTRAL INDEX KEY:			0001069530
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				911911336
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-29959
		FILM NUMBER:		221356519

	BUSINESS ADDRESS:	
		STREET 1:		7801 N CAPITAL OF TEXAS HIGHWAY
		STREET 2:		SUITE 260
		CITY:			AUSTIN
		STATE:			TX
		ZIP:			78731
		BUSINESS PHONE:		512-501-2444

	MAIL ADDRESS:	
		STREET 1:		7801 N CAPITAL OF TEXAS HIGHWAY
		STREET 2:		SUITE 260
		CITY:			AUSTIN
		STATE:			TX
		ZIP:			78731

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PAIN THERAPEUTICS INC
		DATE OF NAME CHANGE:	20000309
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>sava-20221103x8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--Inline XBRL document created by Certent Disclosure Management 1.0.0.0-->
<!--Created on: 11/03/2022 13:09:59 PM-->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:sava="http://www.cassavasciences.com/20221103" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <head>
    <title>sava-20221103x8k</title>
    <meta http-equiv="Content-Type" content="text/html" /></head>
  <body xml:lang="en-US">
    <div style="display:none"><ix:header><ix:hidden><ix:nonNumeric name="dei:AmendmentFlag" id="ct-nonNumeric-2c33e160-aa46-4435-877b-45aff889e3f8" contextRef="Duration_11_3_2022_To_11_3_2022" format="ixt:booleanfalse">false</ix:nonNumeric><ix:nonNumeric name="dei:EntityCentralIndexKey" id="ct-nonNumeric-d2f9fc00-a827-4873-8c15-8cdd589cf83d" contextRef="Duration_11_3_2022_To_11_3_2022">0001069530</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="sava-20221103.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="Duration_11_3_2022_To_11_3_2022"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-03</xbrli:startDate><xbrli:endDate>2022-11-03</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div>
    <div class="headerContainer"></div>
    <div><div style="border-bottom: solid #000000 1.0pt;border-left: none;border-right: none;border-top: none;padding-bottom: 0;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0.5pt;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 18pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 3pt;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 18pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">UNITED STATES</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 18pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 18pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">SECURITIES AND EXCHANGE COMMISSION</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Washington, D.C. 20549</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 10pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">___________________</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 18pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 9pt;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 18pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">FORM </span><ix:nonNumeric name="dei:DocumentType" id="ct-nonNumeric-e67d0746-7966-4968-894b-be4ee28da319" contextRef="Duration_11_3_2022_To_11_3_2022"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 18pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">8-K</span></ix:nonNumeric></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 10pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">___________________</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 13.5pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 9pt;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 13.5pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">CURRENT REPORT</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 9pt;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Pursuant to Section&#160;13 or 15(d) of the</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Securities Exchange Act of 1934</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 9pt;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Date of Report (Date of earliest event reported) </span><ix:nonNumeric name="dei:DocumentPeriodEndDate" id="ct-nonNumeric-14b54c8c-847b-46e6-b4f1-82c0d9450db3" contextRef="Duration_11_3_2022_To_11_3_2022" format="ixt:datemonthdayyearen"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">November 3, 2022</span></ix:nonNumeric></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 10pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">___________________</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 24pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 9pt;text-align: center;"><ix:nonNumeric name="dei:EntityRegistrantName" id="ct-nonNumeric-d0e2577d-902e-4adc-a243-d6fa3737ce5c" contextRef="Duration_11_3_2022_To_11_3_2022"><span style="white-space:pre-wrap; font-family: Sansation;font-size: 24pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Cassava Sciences, Inc.</span></ix:nonNumeric></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">(Exact name of registrant as specified in its charter)</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 10pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">___________________</span></p><div style="text-align:left"><table dir="ltr" style="border: none;border-collapse: collapse;margin-bottom: .001pt;margin-left: 0;margin-right: auto;width: 100%;"><tr style="height: 0.01in;"><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 29.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 39.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 28.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 29.1%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.01in;margin-top: 0;text-align: center;"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" id="ct-nonNumeric-9c983e58-a8da-4469-b1c8-52f956560b30" contextRef="Duration_11_3_2022_To_11_3_2022" format="ixt-sec:stateprovnameen"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Delaware</span></ix:nonNumeric><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 39.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.01in;margin-top: 0;text-align: center;"><ix:nonNumeric name="dei:EntityFileNumber" id="ct-nonNumeric-7ab3e5db-9430-4de8-ba6c-4ace80dfc6f2" contextRef="Duration_11_3_2022_To_11_3_2022"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">000-29959</span></ix:nonNumeric><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 28.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" id="ct-nonNumeric-df940cc1-4c78-409e-aa67-63a9802095ca" contextRef="Duration_11_3_2022_To_11_3_2022"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">91-1911336</span></ix:nonNumeric><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 29.1%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.01in;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">(State or other jurisdiction</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.01in;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">of incorporation)</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.01in;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 39.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.01in;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">(Commission</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.01in;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">File Number)</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.01in;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 28.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.01in;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">(I.R.S. Employer</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.01in;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Identification Number)</span></p></td></tr></table></div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 9pt;text-align: center;"><ix:nonNumeric name="dei:EntityAddressAddressLine1" id="ct-nonNumeric-21f39458-1ff8-4c5a-9834-6f049f75da26" contextRef="Duration_11_3_2022_To_11_3_2022"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">6801 N Capital of Texas Highway</span></ix:nonNumeric><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">, </span><ix:nonNumeric name="dei:EntityAddressAddressLine2" id="ct-nonNumeric-743b86ac-ce23-49fb-a285-dc53d2d3ae3d" contextRef="Duration_11_3_2022_To_11_3_2022"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Building 1; Suite 300</span></ix:nonNumeric></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><ix:nonNumeric name="dei:EntityAddressCityOrTown" id="ct-nonNumeric-9ec22fa6-f456-4358-9e74-79a796bd2364" contextRef="Duration_11_3_2022_To_11_3_2022"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Austin</span></ix:nonNumeric><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">, </span><ix:nonNumeric name="dei:EntityAddressStateOrProvince" id="ct-nonNumeric-feeaac54-b06a-4cba-8f45-20b269d7e228" contextRef="Duration_11_3_2022_To_11_3_2022" format="ixt-sec:stateprovnameen"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Texas</span></ix:nonNumeric><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><ix:nonNumeric name="dei:EntityAddressPostalZipCode" id="ct-nonNumeric-c8247d0a-97ca-42ff-8328-7ba885f4753b" contextRef="Duration_11_3_2022_To_11_3_2022"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">78731</span></ix:nonNumeric></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 7.5pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 7.5pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">(Address of principal executive offices, including zip code)</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 9pt;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">(</span><ix:nonNumeric name="dei:CityAreaCode" id="ct-nonNumeric-a17f4c40-84fb-4597-b51f-ecce98652cfd" contextRef="Duration_11_3_2022_To_11_3_2022"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">512</span></ix:nonNumeric><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">) </span><ix:nonNumeric name="dei:LocalPhoneNumber" id="ct-nonNumeric-8542bf50-13c7-4dc2-bc74-6031aa89f2c3" contextRef="Duration_11_3_2022_To_11_3_2022"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">501-2444</span></ix:nonNumeric></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 7.5pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 7.5pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">(Registrant&#8217;s telephone number, including area code)</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 7.5pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 7.5pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 7.5pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 7.5pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">(Former name or former address, if changed since last report.)</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 10pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">___________________</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2 below):</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 5pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 5pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p><div style="text-align:left"><table dir="ltr" style="border: none;border-collapse: collapse;margin-bottom: .001pt;margin-left: 0;margin-right: auto;width: 100%;"><tr style="height: 0.01in;"><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 19.45pt;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 19.45pt;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0.01in;margin-top: 0;"><ix:nonNumeric name="dei:WrittenCommunications" id="ct-nonNumeric-93a0ec63-23eb-4e73-b231-2d507aa25db6" contextRef="Duration_11_3_2022_To_11_3_2022" format="ixt:booleanfalse"><span style="white-space:pre-wrap; font-family: Wingdings;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#61608;</span></ix:nonNumeric></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0.01in;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">ThereWritten communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 19.45pt;"><p dir="ltr" style="text-align:left; font-family: Wingdings;font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0.01in;margin-top: 0;"><ix:nonNumeric name="dei:SolicitingMaterial" id="ct-nonNumeric-71295f04-bf0a-49d1-9b15-84617a86de06" contextRef="Duration_11_3_2022_To_11_3_2022" format="ixt:booleanfalse"><span style="white-space:pre-wrap; font-family: Wingdings;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#61608;</span></ix:nonNumeric></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0.01in;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 19.45pt;"><p dir="ltr" style="text-align:left; font-family: Wingdings;font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0.01in;margin-top: 0;"><ix:nonNumeric name="dei:PreCommencementTenderOffer" id="ct-nonNumeric-be033387-c4c4-4c43-9c87-eb1de48e0da3" contextRef="Duration_11_3_2022_To_11_3_2022" format="ixt:booleanfalse"><span style="white-space:pre-wrap; font-family: Wingdings;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#61608;</span></ix:nonNumeric></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0.01in;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17CFR 240.14d-2(b))</span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 19.45pt;"><p dir="ltr" style="text-align:left; font-family: Wingdings;font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0.01in;margin-top: 0;"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" id="ct-nonNumeric-b2985afa-82eb-4a65-bfeb-2250af63c1c7" contextRef="Duration_11_3_2022_To_11_3_2022" format="ixt:booleanfalse"><span style="white-space:pre-wrap; font-family: Wingdings;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#61608;</span></ix:nonNumeric></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0.01in;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17CFR 240.13e-4(c))</span></p></td></tr></table></div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 6pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 5pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 6pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Securities registered pursuant to Section 12(b) of the Act:</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p><div style="text-align:left"><table dir="ltr" style="border: none;border-collapse: collapse;margin-bottom: .001pt;margin-left: 0;margin-right: auto;width: 100%;"><tr style="height: 0.01in;"><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 38.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 15.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 45.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="border-bottom: solid #000000 1.0pt;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 38.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Title of each class</span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 1.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 15.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Trading</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Symbol(s)</span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 1.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 45.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Name of each exchange on which registered</span></p></td></tr><tr><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 205.2pt;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><ix:nonNumeric name="dei:Security12bTitle" id="ct-nonNumeric-768fc76d-72fb-4427-aa72-266a493223e2" contextRef="Duration_11_3_2022_To_11_3_2022"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Common Stock, $0.001 par value</span></ix:nonNumeric><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 5.4pt;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 81pt;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><ix:nonNumeric name="dei:TradingSymbol" id="ct-nonNumeric-28121358-624f-416d-9fd8-76144d7e8b8d" contextRef="Duration_11_3_2022_To_11_3_2022"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">SAVA</span></ix:nonNumeric><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 5.4pt;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 243pt;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><ix:nonNumeric name="dei:SecurityExchangeName" id="ct-nonNumeric-921c9cf2-d1d8-4ca7-8703-861d0fbaddc5" contextRef="Duration_11_3_2022_To_11_3_2022"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">NASDAQ</span></ix:nonNumeric><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> Capital Market</span></p></td></tr></table></div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Emerging growth company   </span><ix:nonNumeric name="dei:EntityEmergingGrowthCompany" id="ct-nonNumeric-8f49d2c8-9e86-469c-9fa0-aec4307a8bdf" contextRef="Duration_11_3_2022_To_11_3_2022" format="ixt:booleanfalse"><span style="white-space:pre-wrap; font-family: Wingdings;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#61608;</span></ix:nonNumeric></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.</span><span style="white-space:pre-wrap; font-family: Wingdings;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#61472;&#61608;</span></p><div style="border-bottom: solid #000000 1.0pt;border-left: none;border-right: none;border-top: none;padding-bottom: 0;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0.5pt;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 2pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 2pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><br />&#8206;</span><span style="white-space:pre-wrap; font-size: 2pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></div>
    <div><div class="footerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></div><hr class="pageBreak" style="margin:18pt 0pt; ct-page-break: true; page-break-after: always;" /><div class="headerContainer"></div></div>
    <div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 5pt;margin-left: 0;margin-right: 0;margin-top: 5pt;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Item 7.01. Regulation FD Disclosure.</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 6pt;"><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">A copy of the Company&#8217;s press release issued on November 3, 2022 is attached hereto&#160;as Exhibit 99.1 and is incorporated herein by reference.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 6pt;"><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The information provided in this Current Report is being furnished and shall not be deemed &#8220;filed&#8221; for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that Section. Such information shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any incorporation by reference language in such filing.</span></p><p dir="ltr" style="background: #FFFFFF;font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="background: #FFFFFF;font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Item 9.01. Financial Statements and Exhibits.</span></p><div style="text-align:left"><table dir="ltr" style="border: none;border-collapse: collapse;margin-bottom: .001pt;margin-left: 0;margin-right: auto;width: 100%;"><tr style="height: 0.01in;"><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 14.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 84.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: middle;width: 14.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: middle;width: 1.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: middle;width: 84.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td></tr><tr><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 14.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;text-decoration: underline;">Exhibit Number</span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: middle;width: 1.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 84.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;text-decoration: underline;">Description</span></p></td></tr><tr><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 14.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: middle;width: 1.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 84.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 14.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">99.1</span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: middle;width: 1.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 84.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="sava-20221103xex99_1.htm"><span style="white-space:pre-wrap; background: #FFFFFF;color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Press Release issued by Cassava Sciences, Inc. on November 3, 2022</span></a></p></td></tr><tr><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 14.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">104</span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: middle;width: 1.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 84.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></p></td></tr></table></div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><br />&#8206;</span><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></div>
    <div><div class="footerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></div><hr class="pageBreak" style="margin:18pt 0pt; ct-page-break: true; page-break-after: always;" /><div class="headerContainer"></div></div>
    <div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">SIGNATURE</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: left;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: left;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: left;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span></p><div style="padding-left: 0;text-align:left"><table dir="ltr" style="border: none;border-collapse: collapse;margin-bottom: .001pt;margin-left: 0;margin-right: auto;width: 100%;"><tr style="height: 0.01in;"><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 38.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 7.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 37.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 16.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 38.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: left;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 45.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span id="_Hlk8292710" style="text-decoration: none;"></span><span style="white-space:pre-wrap; font-family: Sansation;font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">CASSAVA SCIENCES, INC.</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 16.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: left;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 38.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: left;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 45.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">a Delaware corporation</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 16.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: left;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 38.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: left;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 7.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: left;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 37.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: left;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 16.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: left;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 38.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: left;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Date:   November 3, 2022</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 7.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: left;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 37.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: left;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 16.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: left;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 38.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: left;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 7.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: left;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">By:</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 37.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: left;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">/s/ ERIC J. SCHOEN</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 16.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: left;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 38.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: left;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 7.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: left;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 37.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: left;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Eric J. Schoen</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 16.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: left;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 38.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: left;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 7.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: left;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 37.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: left;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Chief Financial Officer</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 16.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: left;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span></p></td></tr></table></div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></div>
    <div class="footerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>sava-20221103xex99_1.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!--HTML document created with Certent Disclosure Management 22.2.0.1-->
<!--Created on: 11/3/2022 8:10:13 AM-->
<html>
	<head>
		<title>
			Exhibit 991 - Legal Complaint
		</title>
	</head>
	<body><div style="margin-left:72pt;margin-right:72pt;"><div style="width:100%">

		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 12pt">
			<a name="_Hlk6492065"></a><font style="display: inline;"><img src="sava-20221103xex99_1g001.jpg" style="width: 5.409161in; height: 1.768203in" alt="Picture 1"></font>
		</p>
		<p style="margin:0pt 0pt 3pt;text-align:right;font-family:Times New Roman;font-size: 14pt">
			<font style="display: inline;font-family:Calibri;font-weight:bold;font-size:14pt;">Exhibit 99.1</font>
		</p>
		<p style="margin:0pt 0pt 3pt;text-align:center;font-family:Times New Roman;font-size: 22pt">
			<font style="display: inline;font-family:Sansation;font-weight:bold;font-size:22pt;">Cassava Sciences</font><font style="display: inline;font-family:Sansation;font-weight:bold;font-size:22pt;">&nbsp;</font><font style="display: inline;font-family:Sansation;font-weight:bold;font-size:22pt;">Files </font><font style="display: inline;font-family:Sansation;font-weight:bold;font-size:22pt;">Lawsuit </font><font style="display: inline;font-family:Sansation;font-weight:bold;font-size:22pt;">Against </font><font style="display: inline;font-family:Sansation;font-weight:bold;font-size:22pt;">Perpetrators</font><font style="display: inline;font-family:Sansation;font-weight:bold;font-size:22pt;"> of</font><font style="display: inline;font-family:Sansation;font-weight:bold;font-size:22pt;">&nbsp;</font><font style="display: inline;font-family:Sansation;font-weight:bold;font-size:22pt;">&#x201C;Short and Distort&#x201D; Campaign</font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 14pt">
			<font style="display: inline;font-family:Calibri;font-weight:bold;font-size:14pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;font-weight:bold;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;line-height:150%;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;font-weight:bold;">AUSTIN, Texas &#x2013; </font><font style="display: inline;font-family:Calibri;font-weight:bold;">November</font><font style="display: inline;font-family:Calibri;font-weight:bold;">&nbsp;</font><font style="display: inline;font-family:Calibri;font-weight:bold;">3</font><font style="display: inline;font-family:Calibri;font-weight:bold;">,</font><font style="display: inline;font-family:Calibri;font-weight:bold;"> 20</font><font style="display: inline;font-family:Calibri;font-weight:bold;">2</font><font style="display: inline;font-family:Calibri;font-weight:bold;">2</font><font style="display: inline;font-family:Calibri;"> &#x2013; </font><font style="display: inline;font-family:Calibri;">Cassava Sciences</font><font style="display: inline;font-family:Calibri;">, Inc. (Nasdaq: </font><font style="display: inline;font-family:Calibri;">SAVA), a </font><font style="display: inline;font-family:Calibri;">clinical-stage </font><font style="display: inline;font-family:Calibri;">biotechnology </font><font style="display: inline;font-family:Calibri;">company, today </font><font style="display: inline;font-family:Calibri;">announced</font><font style="display: inline;font-family:Calibri;">&nbsp;</font><font style="display: inline;font-family:Calibri;">that </font><font style="display: inline;font-family:Calibri;">it</font><font style="display: inline;font-family:Calibri;">&nbsp;</font><font style="display: inline;font-family:Calibri;">has</font><font style="display: inline;font-family:Calibri;"> filed a </font><font style="display: inline;font-family:Calibri;">lawsuit</font><font style="display: inline;font-family:Calibri;"> in</font><font style="display: inline;font-family:Calibri;"> federal court </font><font style="display: inline;font-family:Calibri;">against </font><font style="display: inline;font-family:Calibri;">certain </font><font style="display: inline;font-family:Calibri;">individuals who </font><font style="display: inline;font-family:Calibri;">executed a </font><font style="display: inline;font-family:Calibri;">&#x201C;short and distort&#x201D; campaign </font><font style="display: inline;font-family:Calibri;">against the Company</font><font style="display: inline;font-family:Calibri;">. &nbsp;</font><font style="display: inline;font-family:Calibri;">The 150+ page complaint alleges that the Defendants&#x2019; disinformation campaign</font><font style="display: inline;font-family:Calibri;"> caused</font><font style="display: inline;font-family:Calibri;">&nbsp;</font><font style="display: inline;font-family:Calibri;">a &nbsp;</font><font style="display: inline;font-family:Calibri;">precipitous</font><font style="display: inline;font-family:Calibri;"> decline in Cassava Sciences&#x2019; stock price</font><font style="display: inline;font-family:Calibri;">,</font><font style="display: inline;font-family:Calibri;">&nbsp;</font><font style="display: inline;font-family:Calibri;">a &nbsp;</font><font style="display: inline;font-family:Calibri;">multi-billion</font><font style="display: inline;font-family:Calibri;">&nbsp;</font><font style="display: inline;font-family:Calibri;">dollar</font><font style="display: inline;font-family:Calibri;">&nbsp;</font><font style="display: inline;font-family:Calibri;">decline in </font><font style="display: inline;font-family:Calibri;">its </font><font style="display: inline;font-family:Calibri;">market capitalization,</font><font style="display: inline;font-family:Calibri;"> and delayed the Company&#x2019;s work in developing a treatment for Alzheimer&#x2019;s disease</font><font style="display: inline;font-family:Calibri;">.</font><font style="display: inline;font-family:Calibri;">&nbsp;</font>
		</p>
		<p style="margin:0pt;line-height:150%;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;line-height:150%;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;">The lawsuit alleges: &#x201C;</font><font style="display: inline;font-family:Calibri;">Defendants placed personal enrichment over science, over the health of patients, and over the truth. Defendants saw an opportunity to manipulate a stock price and financially benefit from their </font><font style="display: inline;font-family:Calibri;">&#x2018;s</font><font style="display: inline;font-family:Calibri;">hort positions</font><font style="display: inline;font-family:Calibri;">&#x2019;</font><font style="display: inline;font-family:Calibri;"> by defaming a company developing a drug for people with Alzheimer&#x2019;s disease, a condition that afflicts millions of </font><font style="display: inline;font-family:Calibri;">people</font><font style="display: inline;font-family:Calibri;">. Defendants seized that opportunity and, while enriching themselves, caused irreparable harm to the company, its attempts to find a treatment for the disease, and patients waiting for that treatment. Defendants&#x2019; conduct is beyond shameful. It is </font><font style="display: inline;font-family:Calibri;">unlawful.&#x201D;</font>
		</p>
		<p style="margin:0pt;line-height:150%;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;line-height:150%;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;">The complaint identifies over </font><font style="display: inline;font-family:Calibri;">1,000 </font><font style="display: inline;font-family:Calibri;">false and defamatory statements made by the Defendants in submissions to the U.S. Food and Drug Administration as well as &#x201C;reports&#x201D; and presentations </font><font style="display: inline;font-family:Calibri;">that </font><font style="display: inline;font-family:Calibri;">Defendants published online</font><font style="display: inline;font-family:Calibri;"> or</font><font style="display: inline;font-family:Calibri;">&nbsp;</font><font style="display: inline;font-family:Calibri;">on </font><font style="display: inline;font-family:Calibri;">social media. According to the complaint, &#x201C;</font><font style="display: inline;font-family:Calibri;">Defendants saturated the market, investors, federal agencies, testing sites, and others with their false and defamatory message about Cassava. Defendants did not have any real or valid concerns with Cassava, its foundational science, or its tests. Defendants engaged in their saturation campaign to profit based on a decline in Cassava&#x2019;s stock price.</font><font style="display: inline;font-family:Calibri;">&#x201D;</font>
		</p>
		<p style="margin:0pt;line-height:150%;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

		</p>
		<p><font size="1"> </font></p><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 3pt;font-family:Times New Roman;font-size: 12pt">

			<font style="display: inline;font-family:Sansation;font-weight:bold;font-style:italic;">Cassava Sciences, Inc.</font>

		</p>

		<p style="margin:0pt 0pt 3pt;font-family:Times New Roman;font-size: 12pt">

			<font style="display: inline;font-family:Sansation;font-weight:bold;font-style:italic;">November 3, 2022</font>

		</p>

		<p style="margin:0pt 0pt 3pt;font-family:Times New Roman;font-size: 12pt">

			<font style="display: inline;font-family:Sansation;font-weight:bold;font-style:italic;">Page </font><font style="display: inline;font-family:Sansation;font-weight:bold;font-style:italic;"></font><font style="display: inline;font-family:Sansation;font-weight:bold;font-style:italic;">2</font><font style="display: inline;font-family:Sansation;font-weight:bold;font-style:italic;"></font><font style="display: inline;font-family:Sansation;font-weight:bold;font-style:italic;"> of </font><font style="display: inline;font-family:Sansation;font-weight:bold;font-style:italic;"></font><font style="display: inline;font-family:Sansation;font-weight:bold;font-style:italic;">2</font><font style="display: inline;font-family:Sansation;font-weight:bold;font-style:italic;"></font>

		</p>

		<p style="margin:0pt 0pt 3pt;font-family:Times New Roman;font-size: 12pt">

			<font style="display: inline;font-family:Sansation;font-weight:bold;font-style:italic;"></font>

		</p>

</div>
		<p style="margin:0pt;line-height:150%;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;;font-size: 12pt"><font style="display: inline;font-family:Calibri;">Cassava Sciences</font><font style="display: inline;font-family:Calibri;"> has retained J. Erik Connolly, Managing Chair of the Litigation Group at Benesch Friedlander Coplan &amp; Aronoff LLP to represent it in this matter. Mr. Connolly has litigated some of the largest defamation claims in the country, including a $6 billion dollar claim against ABC and multi-billion-dollar claims brought on behalf of a voting technology company against Fox News and others based on their statements following the 2020 U.S. election. </font>
		</p>
		<p style="margin:0pt;line-height:150%;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;line-height:150%;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;">&#x201C;</font><font style="display: inline;font-family:Calibri;">There are serious consequences when people use disinformation as a way to deflate a company&#x2019;s stock price and make money by shorting the stock,&#x201D;</font><font style="display: inline;font-family:Calibri;"> said Mr.</font><font style="display: inline;font-family:Calibri;">&nbsp;</font><font style="display: inline;font-family:Calibri;">Connolly</font><font style="display: inline;font-family:Calibri;">. &#x201C;These actions not only financially hurt the Company and its investors, but they also cast a permanent cloud over research being done to try to find a </font><font style="display: inline;font-family:Calibri;">treatment </font><font style="display: inline;font-family:Calibri;">for a terrible disease. That is just wrong.&#x201D;</font>
		</p>
		<p style="margin:0pt;line-height:150%;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;line-height:150%;text-align:justify;text-justify:inter-ideograph;border-bottom:1pt none #D9D9D9 ;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;color:#000000;">&#x201C;We are still investigating whether additional individuals or entities should be brought into this case or have separate claims brought against them,&#x201D; according to Mr. Connolly.&nbsp; </font>
		</p>
		<p style="margin:0pt;line-height:150%;text-align:justify;text-justify:inter-ideograph;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:310pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-family:Calibri;color:#000000;"></font></font>
		</p>
		<p style="margin:0pt;line-height:150%;text-align:justify;text-justify:inter-ideograph;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;">The filing of this lawsuit marks another step in Cassava Sciences&#x2019; vigorous defense of itself and </font><font style="display: inline;font-family:Calibri;">its</font><font style="display: inline;font-family:Calibri;"> stakeholders</font><font style="display: inline;font-family:Calibri;">. It</font><font style="display: inline;font-family:Calibri;"> follows </font><font style="display: inline;font-family:Calibri;">Cassava Sciences&#x2019; </font><font style="display: inline;font-family:Calibri;">press releases </font><font style="display: inline;font-family:Calibri;">denying the disinformation being disseminated by Defendants, including: </font><font style="display: inline;font-family:Calibri;font-style:italic;">N</font><font style="display: inline;font-family:Calibri;font-style:italic;">o &nbsp;</font><font style="display: inline;font-family:Calibri;font-style:italic;">E</font><font style="display: inline;font-family:Calibri;font-style:italic;">vidence of </font><font style="display: inline;font-family:Calibri;font-style:italic;">D</font><font style="display: inline;font-family:Calibri;font-style:italic;">ata </font><font style="display: inline;font-family:Calibri;font-style:italic;">M</font><font style="display: inline;font-family:Calibri;font-style:italic;">anipulation in </font><font style="display: inline;font-family:Calibri;font-style:italic;">S</font><font style="display: inline;font-family:Calibri;font-style:italic;">cience </font><font style="display: inline;font-family:Calibri;font-style:italic;">P</font><font style="display: inline;font-family:Calibri;font-style:italic;">ublication on </font><font style="display: inline;font-family:Calibri;font-style:italic;">S</font><font style="display: inline;font-family:Calibri;font-style:italic;">imufilam</font><font style="display: inline;font-family:Calibri;"> (August 18, 2022), </font><font style="display: inline;font-family:Calibri;font-style:italic;">FDA </font><font style="display: inline;font-family:Calibri;font-style:italic;">D</font><font style="display: inline;font-family:Calibri;font-style:italic;">enies Citizen Petition </font><font style="display: inline;font-family:Calibri;font-style:italic;">F</font><font style="display: inline;font-family:Calibri;font-style:italic;">iled on </font><font style="display: inline;font-family:Calibri;font-style:italic;">B</font><font style="display: inline;font-family:Calibri;font-style:italic;">ehalf of </font><font style="display: inline;font-family:Calibri;font-style:italic;">S</font><font style="display: inline;font-family:Calibri;font-style:italic;">hort </font><font style="display: inline;font-family:Calibri;font-style:italic;">S</font><font style="display: inline;font-family:Calibri;font-style:italic;">ell</font><font style="display: inline;font-family:Calibri;font-style:italic;">ing Clients</font><font style="display: inline;font-family:Calibri;"> (February 10, 2022), </font><font style="display: inline;font-family:Calibri;font-style:italic;">S</font><font style="display: inline;font-family:Calibri;font-style:italic;">cience </font><font style="display: inline;font-family:Calibri;font-style:italic;">J</font><font style="display: inline;font-family:Calibri;font-style:italic;">ournal </font><font style="display: inline;font-family:Calibri;font-style:italic;">F</font><font style="display: inline;font-family:Calibri;font-style:italic;">inds </font><font style="display: inline;font-family:Calibri;font-style:italic;">N</font><font style="display: inline;font-family:Calibri;font-style:italic;">o &nbsp;</font><font style="display: inline;font-family:Calibri;font-style:italic;">E</font><font style="display: inline;font-family:Calibri;font-style:italic;">vidence to </font><font style="display: inline;font-family:Calibri;font-style:italic;">S</font><font style="display: inline;font-family:Calibri;font-style:italic;">upport </font><font style="display: inline;font-family:Calibri;font-style:italic;">C</font><font style="display: inline;font-family:Calibri;font-style:italic;">laims of </font><font style="display: inline;font-family:Calibri;font-style:italic;">D</font><font style="display: inline;font-family:Calibri;font-style:italic;">ata </font><font style="display: inline;font-family:Calibri;font-style:italic;">M</font><font style="display: inline;font-family:Calibri;font-style:italic;">anipulation in 2005 </font><font style="display: inline;font-family:Calibri;font-style:italic;">P</font><font style="display: inline;font-family:Calibri;font-style:italic;">ublication</font><font style="display: inline;font-family:Calibri;"> (December 21, 2021), </font><font style="display: inline;font-family:Calibri;font-style:italic;">Review by Journal of Neuroscience Shows No Evidence of Data Manipulation in Technical Paper Foundational to Cassava Sciences&#x2019; Lead Drug Candidate</font><font style="display: inline;font-family:Calibri;">&nbsp;</font><font style="display: inline;font-family:Calibri;">(November 4, 2021), </font><font style="display: inline;font-family:Calibri;font-style:italic;">Cassava Sciences Releases a Public Statement Regarding Recent Allegations</font><font style="display: inline;font-family:Calibri;">&nbsp;</font><font style="display: inline;font-family:Calibri;">(September 3, 2021), </font><font style="display: inline;font-family:Calibri;">and </font><font style="display: inline;font-family:Calibri;font-style:italic;">Cassava Sciences Responds to Allegations </font><font style="display: inline;font-family:Calibri;">(</font><font style="display: inline;font-family:Calibri;">August 2</font><font style="display: inline;font-family:Calibri;">5</font><font style="display: inline;font-family:Calibri;">, 2021).</font>
		</p>
		<p style="margin:0pt;line-height:150%;text-align:justify;text-justify:inter-ideograph;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;line-height:150%;text-align:justify;text-justify:inter-ideograph;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;font-family:Times New Roman;font-size: 12pt">
			<font style="font-weight:bold;display: inline;font-family:Calibri;">About Simufilam</font>
		</p>
		<p style="margin:0pt;line-height:150%;text-align:justify;text-justify:inter-ideograph;border-top:1pt none #D9D9D9 ;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;">Simufilam (sim-uh-FILL-am) is Cassava Sciences&#x2019; proprietary, small molecule (oral) drug that restores the normal shape and function of altered filamin A (FLNA) protein in the brain. Cassava Sciences owns worldwide development and commercial rights to its research programs in Alzheimer&#x2019;s disease, and related technologies, without royalty obligations to any third party. </font>
		</p>
		<p style="margin:0pt;line-height:150%;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="font-weight:bold;display: inline;font-family:Calibri;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;line-height:150%;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

		</p>
		<p><font size="1"> </font></p><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt 0pt 3pt;font-family:Times New Roman;font-size: 12pt">

			<font style="display: inline;font-family:Sansation;font-weight:bold;font-style:italic;">Cassava Sciences, Inc.</font>

		</p>

		<p style="margin:0pt 0pt 3pt;font-family:Times New Roman;font-size: 12pt">

			<font style="display: inline;font-family:Sansation;font-weight:bold;font-style:italic;">November 3, 2022</font>

		</p>

		<p style="margin:0pt 0pt 3pt;font-family:Times New Roman;font-size: 12pt">

			<font style="display: inline;font-family:Sansation;font-weight:bold;font-style:italic;">Page </font><font style="display: inline;font-family:Sansation;font-weight:bold;font-style:italic;"></font><font style="display: inline;font-family:Sansation;font-weight:bold;font-style:italic;">3</font><font style="display: inline;font-family:Sansation;font-weight:bold;font-style:italic;"></font><font style="display: inline;font-family:Sansation;font-weight:bold;font-style:italic;"> of </font><font style="display: inline;font-family:Sansation;font-weight:bold;font-style:italic;"></font><font style="display: inline;font-family:Sansation;font-weight:bold;font-style:italic;">2</font><font style="display: inline;font-family:Sansation;font-weight:bold;font-style:italic;"></font>

		</p>

		<p style="margin:0pt 0pt 3pt;font-family:Times New Roman;font-size: 12pt">

			<font style="display: inline;font-family:Sansation;font-weight:bold;font-style:italic;"></font>

		</p>

</div>
		<p style="margin:0pt;line-height:150%;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;;font-size: 12pt"><font style="font-weight:bold;display: inline;font-family:Calibri;">About </font><font style="display: inline;font-family:Calibri;font-weight:bold;">Cassava Sciences, Inc.</font>
		</p>
		<p style="margin:0pt;line-height:150%;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;">Cassava Sciences, Inc. is a clinical-stage biotechnology company based in Austin, Texas. Our mission is to detect and treat neurodegenerative diseases, such as Alzheimer&#x2019;s disease. Our novel science is based on stabilizing</font><font style="display: inline;font-family:Calibri;font-size:11pt;">&#x2014;</font><font style="display: inline;font-family:Calibri;">but not removing</font><font style="display: inline;font-family:Calibri;font-size:11pt;">&#x2014;</font><font style="display: inline;font-family:Calibri;">a critical protein in the brain. The Company&#x2019;s product candidates have not been approved by any regulatory authority and their safety, efficacy</font><font style="display: inline;font-family:Calibri;"> or </font><font style="display: inline;font-family:Calibri;">other desirable attributes have not been</font><font style="display: inline;font-family:Calibri;"> established</font><font style="display: inline;font-family:Calibri;">.</font><font style="display: inline;font-family:Calibri;">&nbsp;</font>
		</p>
		<p style="margin:0pt;line-height:150%;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;line-height:150%;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;">For more information, please visit: https://www.CassavaSciences.com&nbsp; </font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;font-weight:bold;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;font-weight:bold;">For More Information Contact:</font><font style="display: inline;font-family:Calibri;font-weight:bold;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;">Eric Schoen, Chief Financial Officer</font><font style="display: inline;font-family:Calibri;">, &nbsp;</font><font style="display: inline;font-family:Calibri;">(512) 501-2450</font><font style="display: inline;font-family:Calibri;">, or</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:262.25pt;"><font style="display: inline;font-family:Calibri;">eschoen@CassavaSciences.com</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-family:Calibri;"></font></font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-family:Calibri;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-family:Calibri;font-size:11pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;border-bottom:1pt none #D9D9D9 ;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-family:Calibri;font-weight:bold;font-style:italic;font-size:11pt;">Cautionary Note Regarding Forward-Looking Statements:</font><font style="display: inline;font-family:Calibri;font-style:italic;font-size:11pt;">&nbsp;</font><font style="display: inline;font-family:Calibri;font-style:italic;font-size:11pt;">This news release contains forward-looking statements, including statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, relating to our </font><font style="display: inline;font-family:Calibri;font-style:italic;font-size:11pt;">legal </font><font style="display: inline;font-family:Calibri;font-style:italic;font-size:11pt;">strategy and plans</font><font style="display: inline;font-family:Calibri;font-style:italic;font-size:11pt;"> and their expected outcomes. These</font><font style="display: inline;font-family:Calibri;font-style:italic;font-size:11pt;"> statements may be identified by words such as &#x201C;may,&#x201D; &#x201C;anticipate,&#x201D; &#x201C;believe,&#x201D; &#x201C;could,&#x201D; &#x201C;expect,&#x201D; &#x201C;would&#x201D;, &#x201C;forecast,&#x201D; &#x201C;intend,&#x201D; &#x201C;plan,&#x201D; &#x201C;possible,&#x201D; &#x201C;potential,&#x201D; and other words and terms of similar meaning. </font><font style="font-style:italic;display: inline;font-family:Calibri;font-size:11pt;">Such statements are based largely on our current expectations and projections about future events. Such statements speak only as of the date of this news release and are subject to a number of risks, uncertainties and assumptions, including, but not limited to, those risks relating to </font><font style="font-style:italic;display: inline;font-family:Calibri;font-size:11pt;">the filing of a legal complaint</font><font style="font-style:italic;display: inline;font-family:Calibri;font-size:11pt;">, our allegations and claims in the legal complaint,</font><font style="font-style:italic;display: inline;font-family:Calibri;font-size:11pt;"> and including those described in the section entitled &#x201C;Risk Factors&#x201D; in our Annual Report on Form 10-K for the year ended December 31, 2021, and future reports to be filed with the SEC. </font><font style="display: inline;font-family:Calibri;font-style:italic;font-size:11pt;">The foregoing sets forth many, but not all, of the factors that could cause actual results to differ from expectations in any forward-looking statement. </font><font style="font-style:italic;display: inline;font-family:Calibri;font-size:11pt;">In light of these risks, uncertainties and assumptions, the forward-looking statements and events discussed in this news release are inherently uncertain and may not occur, and actual results could differ materially and adversely from those anticipated or implied in the forward-looking statements. Accordingly, you should not rely upon forward-looking statements as predictions of future events. Except as required by law, we disclaim any intention or responsibility for updating or revising any forward-looking statements contained in this news release. For further information regarding these and other risks related to our business, investors should consult our filings with the SEC, which are available on the SEC's website at </font><font style="font-style:italic;display: inline;font-family:Calibri;color:#0000FF;font-size:11pt;text-decoration:underline;">www.sec.gov</font><font style="font-style:italic;display: inline;font-family:Calibri;font-size:11pt;">.</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;border-top:1pt none #D9D9D9 ;font-family:Times New Roman;font-size: 10pt">
			<font style="font-style:italic;display: inline;font-family:Calibri;font-size:10pt;background-color:yellow;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-weight:bold;font-size:11pt;">###</font>
		</p>
		<p><font size="1"> </font></p><hr size="3" style="color:#999999" width="100%" align="center"></hr>
	</div></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>sava-20221103xex99_1g001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 sava-20221103xex99_1g001.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" &%!*8# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M(_-*M-TY.(4445[)D%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4450UK4AIMDSC_6-\J#WK"M6AAZ<JM1V2
MU*C%SDHK=F!XIU+[1<"V0YCC^][M_P#6K"I68LQ).2>2:2OP[&XJ>-KRKSZ_
M@NB/J:=-4H*""BBBN(U"O,_&FA_V7J7GQC%O<$L..%;N*],JAKFDIK.FRVS
M;R,HWHPZ5SUZ7M86ZGH8'$_5JJD]GN>0T4Z:%[>5XI%V2(2K*>Q%-KY\^ZWU
M04444#"BBB@ KO/!>C_8[,WD@_?3#Y<]E_\ KUR_AS23J^I(A'[F/YY#[>GX
MUZ6 %  & . !VJXKJ?+9UB^6*P\.N_\ D+1116I\@%%%% '?>%]6_M&Q".<S
MP_*WN.QK:KS31]2;2[^.8?<Z./5:])CD6:-70[D89!]17[KPSFG]H83V=1_O
M(:/S71_Y^9XV(I^SE=;,=1117V!RA1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MSURBO(_^&A+7_H#2_P#?X?X4?\-"6O\ T!I?^_P_PH_L_$_R_BO\P_L/,/\
MGU^*_P SURBO(_\ AH2U_P"@-+_W^'^%'_#0EK_T!I?^_P /\*/[/Q/\OXK_
M ##^P\P_Y]?BO\ST3Q5HHUK2W51_I$0+Q'OGN/QKS;2=-DU34([8 C)^<_W0
M.M2_\-"6O_0&E_[_  _PKK=+FDATF#Q"^DM9)JWSI&S\J!T[<9ZX]JQ?#^/Q
MU1+#T[R]8_JQXC$5\AP<JF,CRQ>B>^K\E=^9OPPI;PI%&NV-!M4>U/K%_P"$
MD'_/O_X__P#6H_X20?\ /O\ ^/\ _P!:NC_4[//^@?\ \FA_\D?G+SS -W=3
M\'_D;5%8O_"2#_GW_P#'_P#ZU'_"2#_GW_\ '_\ ZU'^IV>?] __ )-#_P"2
M%_;>7_\ /S\'_D;5%8O_  D@_P"??_Q__P"M1_PD@_Y]_P#Q_P#^M1_J=GG_
M $#_ /DT/_D@_MO+_P#GY^#_ ,C:HK%_X20?\^__ (__ /6H_P"$D'_/O_X_
M_P#6H_U.SS_H'_\ )H?_ "0?VWE__/S\'_D;5%8O_"2#_GW_ /'_ /ZU'_"2
M#_GW_P#'_P#ZU'^IV>?] _\ Y-#_ .2#^V\O_P"?GX/_ "-JM7PWJO\ 9>H+
MN.(9/E?^AKD/^$D'_/O_ ./_ /UJ/^$D'_/O_P"/UU87A?B#!UX5Z5#WHN_Q
M0_\ DB99SE\DXNI^#_R/<00P!'(I:YWP5K+ZII:).NR>,<*3DE>QKHJ_9H<_
M*G4CRRZKMY::&,9QJ+F@[H****LH**** "BBB@ KYE_:8_;Q\$?L_P MQHMJ
M/^$I\8(,'2[.0!+<D<&:3HO;Y>I]J\X_;Z_;8D^%:2?#WP+?*/%T\>=1OXN?
M[.C8<*#T\UA_WR/>ORSN+B6\N);BXEDN+B9S))-*Q9W8G)9B>22>YKW,'E_M
M%[2KMV//KXGE?+#<]M^+G[:/Q9^,EQ*NI>)9M&TQ\XTO16:VA"D8*D@[G!_V
MB:\.VCTI:1F"J2Q  ZDU]'"G&FK05D>9*3D[R8M%=;X+^$?C;XC75O!X9\*:
MMK#7'^JD@M6$3_21@$_6O7?#O_!/OXY^()"LGA :/@XW:C=Q*#[_ "LU3*M3
MA\4DAJ$I;(^=:*^KV_X)C_&U5)^S:&V.PU#D_P#CM<=J_P"P9\==)NFA7P'<
M:@!_RUL[F%D/YN#^E0L30>TU]Y3I5%]EG@&!Z5M^%?B%XG^'$\M]X6\0:CH%
MU@,SV%RT0DV\@. <,,]CQ5[Q3\+?&7@FXN(=>\*ZQI;6YVRO<64@C0CU<#;^
MM<A<2+)9RLC!EV'E3D=*W]V:[HRUB?T.^";Z?4_!F@WEU)YMS<:?;S2R$8W.
MT:DG\236U7/?#O\ Y)_X8_[!=K_Z*6NAKX"6[/I%L%%%%2,***Y_Q_XTT_X=
M^"=;\3:I*D-AI=J]S(SMM!VCA<^YP/QII-NR#;4_-K_@JA\9AXC\=:+\.]/N
M=]EHB?;;]48%3<N,(I]&1,G_ +:5\*5N>._&5]\1/&FN>)]2=WO=6NY+N0R'
M+ ,?E4_[J[5_"L.ONL/25&E&"Z'SU2?M)N05[_\ L-_&K_A2O[0.BW-W,8M"
MUHC2M1RX5%5S^[D;CD(W./>O *-S*0R,4=2&5AU!'(/YUI4@JD'"6S)C)Q:D
MC^C"BO"_V+OC,/C=\ ?#^JW$OF:Q8)_9NH@L6;SH@!N8^K+M<_[U>Z5\'4@Z
M<G"6Z/H8R4DI(****@H**** ([BXBM())IY%AAC4N\DC *JCDDD]!7Y]_M1?
M\%,TT.]OO#'PG2&]NHB8I_$MPN^&-L\B!#PY']YLCVXS3/\ @IQ^TY>:'Y'P
MG\-W?V>6ZA%QKEQ"Q#K&WW+<>FX88^H(K\V0 HP!@5]!@<#&455JKT1YN(Q#
M3Y('2>.OB1XI^)VJG4?%>OW^O7>YF5KR9F6//4(N<(/8 "N;Q2U<T?1=2\0W
M9M=)TZ[U2Z R8;*!YG ]2%!(%?0I**LM$>9JV4Z*]TT#]AWXX>(?LSQ> ;ZT
MM[A0Z3WDL4:[3T)&[</Q%=S%_P $R?C;)&KFUT1"PSM;4.1['Y:P>)HQWFOO
M-52J/:+/E*BOIG7/^"<_QQT5"R>'[/5/]FQO48_^/8K@/$W[)?QD\':<;_5_
MAWK%O: [2\2I.<_[L;,?TIQQ%*6TU]XG3FMT>2;1Z5[9^R[\7O&_A'XN>!M(
MTCQ5JEGH]QJ]M;2Z:+EFMFCDE57'ED[>0>N*\?UC1]1\/2B+5M/O-*D)P$OK
M=X"?H' KLO@#_P ET^'O_8>LO_1RU55*5-WU)BVI*Q^^=9GB3Q)I?@_0[W6=
M:OX-,TNSC,UQ=7#A4C4=23_G-:=?D]_P4B_:6N?B)\0[CX<Z-=,GAGP]-LOA
M&W%W>#J&'=8^@ZC/-?&X7#O$U.1;=3W:U14HW-_]HS_@IYK_ (DO+G1OA7%_
M86CJ-C:Y=1AKN<Y.3&AX12/4%NX(KXC\1>)M8\8:H^I:]JM[K.H.,-=7\[32
M$#H,L3P*S:*^PHT*=!6@CQ)U)5'>3$I:V/"_@W7_ !M="W\/Z)J&M2EQ&18V
MSRA6/0,P&%_$BO:M!_8'^.FN7'E/X'FTM<9\V_N8D7_QUB?TJY5:=/XY)$QC
M*6R/GVBOJ\?\$Q_C:0#]GT(?]Q#_ .QKGO$7_!/7XY>'QF/PI'K'./\ B77<
M;?C\Q7BLEBJ#T4U]Y?L:B^RSYQI-HKT_Q=^S#\6? <<<FN?#_6K1)/NM# +C
M/_?HMBO-M0L[G2;K[-?VTUA<_P#/"ZC:)_\ OE@#6\9QGK%W,VG'='UY_P $
M\?B_XWD^/VA>&)_%.J7?AZXMY$;3;JY:6%5125"*Q.S!],5^M]?C%_P3O_Y.
MJ\,_]<;C_P! -?L[7RV9Q4:RLNAZ^$;=/4****\@[0HHHH *_&C_ (*#_&<_
M%KX_W]E:3^;HGAI3IMJ%;*-*#F:0>A+?*?\ <%?I_P#M3?%V'X(_ WQ-XF:1
M5O5@-M8H6*F2XD!5%!]>K?\  :_"J:XFNYY;BYE:>YF=I)9G.6=V.68^Y))_
M&O?RNC=NJ_1'FXRIHH(91117TAYA]I?\$O?C0?!7Q;O_  -?3[-*\3Q^9;JQ
M4*MY&.#G&273Y0/45^KU?SO^'?$%]X3\0:9KFF3O;:CIMS'=V\T?WD=&R"/>
MOWO^#_Q(L?BY\,_#OB[3V0P:I:),R(<B.3&)(\^JL&7\*^8S2CRS55=3U<)4
MO%P?0[&BBBO#/0,CQ9X;MO%WAV_TB[&8;J(H3_=/56_ @'\*^$-<T:Y\.ZQ>
M:9>(4N;64Q.#[=#^(P:_0:OG/]J3P#M^S>*[5..+>\ '_?#G^7XBO?RG$^SJ
M>QEM+\SBQ5/FCS+H?/%'Z'L1117V)Y)]??L]_$)O&7A'[%>2F35=-Q%*SMEI
M(_X'_+C\*]5KX:^%?C>3P#XTLM1+-]C<^3=(#P8V/)_ X/YU]PP3QW4,<T3B
M2*10Z,O0@C(-?#9EAOJ];FBO=E_3/9P]3GA9[HDHHHKR#J"BBB@ HHK,\2^(
M+7PMH-]JMZP2VM8C(V>_H/Q.!^-.*<FDMQ;:L\;_ &F_B,VE:;#X8T^<I=7B
M^9=M&W*P]E_X$?Y>]?,?3@5J>)_$5UXL\07VKWA)GNI"^TG[J_PK^ P*RZ_0
ML'AUA:*AUZ^IX=6I[2385ZG^SUX!/B[QFE_<Q;]-TLB5]P^5Y/X%]_4BO+HX
MGGD2*)&DED8*J*,DD] !7V_\)_ \?@'P99Z?M_TR1?.NGZ[I&Y(SZ#H/I7+F
M>)]A1Y5O+3_,TP]/GG=[([*BBBOACV0KF_B-XYT_X:>!-=\4:I(J66E6DER^
MYMN\J/E0'U9L*/<BNDKX%_X*J_&<:3X/T7X;6$_^E:O)]NU%4;I;QGY$8?[3
MX(_ZYUT8>DZU6,#*I/V<'(_.'QEXLOO'GB[6O$FIR--?ZM=R7<SMU)8Y /T&
M!^%8]%%?=)65D?/B,H92",@\&OUX_P"";'QL_P"%E? ]?#=_<^;KGA5Q9OYC
M[GDMCS"_L ,H/]ROR(KZ"_87^-!^#'[0&C37,WE:)KA&EW^YB$4.1Y<A'<J^
M /\ >-<&.H^VHM+=:G1AZGLYI]#]KJ***^,/="BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *YCX@>)E
M\-Z#(4;%W<9CA'OW;\!_2NEDD6*-G<[549)] *\ \;>)&\3:Y+.I/V:/]W"O
M^R._XUS5ZGLXZ;L]K*L']:KWDO=CJ_T1RNK:>FKV$]M-SY@^\>2&ZY_.O'[N
MUEL;J6WF7;+&VUA7M=<5\0M##QKJ<0^9<), .W8U\UBJ?-'G6Z/V3*\3[.I[
M*6TOS.$HHHKR#ZT**** "BBB@ HHHH ***55:1E5%+NQ 55&22>@% ':_"'P
M!)\0O&%O:NI_LZWQ/=OCC:#POU8\?3-?8NN:!!K&B2:?M"*$ BQ_ 0/EKE/@
MI\/5\ ^#H8YD U2\Q/=OCG)'"?0#]2:] K[3+Z#PU-2^T]3^?N)\R6;8J4%K
M3C=+S[OY_E8^=;BWDM+B6"5=DL;%&4]B*CKT3XI>'2LB:O ORG"3@?HW]*\[
MK[:E456"DC\/Q6'>&JNF_P"D%%%%;'*%%%% !1110 4444 %:&BV'VZ\&X?N
MT^9O\*H %B !DG@"NSTFQ&GV:I_&WS.?>LJDN5'5AZ?M)Z[(U=-O6TZ\CG3H
MO!7U7TKT*&9;B%)$.489!KS2NF\(ZG]ZRD/^U'_45X]>%US(^LP=7EER/9G4
M4445PGM!1110 5YK^T9\8+;X%?![Q#XPFVO/9P[+2)AD27#G;$I]MQ&?;->E
M5^;/_!6CXC/-JW@SP-;S(884DU6Z1&^8/]R,,/3:6(S77A:/MJT8/8QK3]G!
MR/@3Q!X@U'Q9KVH:WK%W)?:KJ$[W-S<2G+22,<DFJ%%(<XX!8]E49)]A7V^V
MB/ .C^'OP\\0?%3Q=I_AGPOITFIZQ>OMCB0?*BC[SNW14 Y)/\\5^J?[.W_!
M.7P)\*8;35O%T<?C3Q2NV3=<K_H=LXP?W<?\1!R-S=0>@K9_8$_9OMO@G\([
M/6M1M(QXO\11)=WDS*"\,)&8H0>P"D,1ZL<]*^HJ^7QN.E.3ITW9+\3UJ&'4
M5S26I7L=/M=+M8[6RMH;.VC&$A@C"(OT X%6***\4[PHHHH @O;&VU*V>WN[
M>*ZMW&&BF0.C?4'@UX/\7?V&/A!\8DN9;_PS'HVJ3J%.I:*1;2@ 8 P!MQ_P
M'GUKW^BM(5)TW>#L3*,9:212T/2H]"T6PTV%F>&SMX[=&?J510H)]\"KM%%9
ME!1110 5\'?\%4OC0-!\!Z1\.+"?%[KDGVN_"/@K:QGY588Y#OG_ +]U]V75
MU%8VLUS.XB@A1I))&Z*H&23^ K\*/VH/B_/\</C?XE\3M*7L#.;33TW[U2VC
M.U"IQT;!?ZN:]7+:/M*W,]HG'BI\L+=SRNNY^!OPSG^,7Q<\+^#H ^W4[M4N
M&C.&2W7YI7!]0@8_A7#5^B?_  2?^$&^3Q/\2KZWR/\ D$Z:[J".#NF=>X8'
M"_1C7TF*K>QI2F>72A[2:B?('[4'P>/P*^-WB+PG$KC3876XT]I#N+6SC*9/
M=NN:\KK]0?\ @JE\'?\ A(/ .B_$*Q@W7>A2_9+UEZFVE( ..^'V\]@37Y?5
M&$K>WHJ3WZCK0]G-H^Q_^"8_QF/@3XS3>#;VX*:5XICV0HQ)"WB E-H'0LNX
M$_[(K]::_G:T?6+OP]J]CJMA(T5]8SI<P.K%3O1@P&1TSC'T)K][?@G\3+/X
MQ?"GPSXPL75X]4LTDD"J5"3#Y95P><!PP'L!7C9I1Y9JJNIWX2I=.#Z'<444
M5X1Z 5'<3K:V\LS_ '8U+GZ 9J2LWQ,QC\.:JR\,MI*1_P!\&FMP/P7^-WCJ
M;XF?%_QAXFFFDG&H:E-)"9CEEA#$1I]%4 ?A7$TG\3?[Q_G2U^@1BHI)=#YI
MN[N>V_LF?LTW_P"TU\1_['%P^G>']/07&JW\8RR1YP(T_P!M^<9Z $]L5^QW
MPO\ @SX,^#>A0:3X1T&TTFWC7!DC0&:0\99Y#\Q)QGKCVKY#_P""2NFV47PQ
M\9WT>/[0GU1(IO78B'9_Z$U?>-?*9A7G.JZ=]$>QA:<8P4NK"BBBO).T****
M ,?7O!N@^*HV36=%T_5592G^F6R2G!&" 6!Q7@E__P $_?A"OC'0_$VA:1<>
M%]2TF\BO8H],G(@E=) _SHV<Y(QP17TG16L*M2G\,K$2A&6Z.7^*7BQO ?PV
M\4>(T4/)I6FW%XJMT+)&S ?F!7\_EU>RZE>7%Y,[237,C3.[L68EB2<D]>M?
MN9^UU<26W[-7Q#:)MK'29E/T(P?T-?A9'_JT^@KZ#*8KDE+S/-QC]Y(=7U1^
MPS^Q_'^T9KUWKOB3S(O!&DRB*:.-MKWL^ WE ]E (+'_ &@!7RO7[+_\$Y=-
MM;+]DGPA/!"D<UX]U-.ZCF1Q<2+N/OM51^%=F/K2HT;PW>AAAZ:J3LSW[PCX
M)T#P%I$.E^'='L]&L(E5%ALX0@P!@9QRQQW.36W117Q[;;NSW-@HHHI %<KX
MQ^%?@_X@6-W:>(_#.EZO#=)Y<QN;92[+Z;\;A^!KJJ*:DXNZ$TGN?/O@K]AW
MX9_#3XJ6'COPE:7FA7UJ&4:?#/NM-K+@@(PR#[[C7T%115SJ3J.\W<48J.D4
M%%%%9E!117/?$+QKI_PY\#ZYXGU258+#2K22ZE=@2,*,@<<\G _&FDV[(6VK
M/S<_X*H_&A?$7CO1?ASI]SOM-#3[;J*(2 ;F0 HC#H=J;6!_VS7PG6[X\\9W
M_P 1/&FM^)]48F^U:[DNY%+%MFYB0@)[*,*/8"L*ONL/25&E&"Z'S]2?M)N1
M[?\ L>? &/\ :*^,4/AZ_P#-CT*UM);O4)H6VNB!=L>T^OF,G'IFO,/B%X+O
M_ASXZU_POJD7DW^DWDEK(N<C@_*<]\J0:_47_@F#\'QX'^"=QXONX2NI^*I_
M/0M@XM8\K%CN-Q+$CV%>$?\ !5+X-G0?'.B?$6QAVV>LQ_8+XK@ 7$8S&<#^
M\F[)]0*X*>,YL7*ETV7JCHE1M14^I\(U^C/_  2G^-2^7KWPPU"X^=2=3TI'
M8G*GB:-1C  .'_X&:_.:NT^"_P 3;WX.?%/PWXPLCEM,NT>:/>566$G$B,1S
MM*G/X"NW%4?;TG#J84I^SFI'[^451T+6K/Q)HFGZMITPN+"^MX[JWE'1XW4,
MI_$$5>KX8^@"J&O:+;>(M'O--NUWV]U$T3\#(!&,CW'6K]%--Q=T&Y\ ^*?#
MESX1\17^CW8Q-:RE-V#AU_A89[$5E5]*_M1> ?MEA;^*;2/][;8AN@HY:,GY
M6_ \?0U\U5^A8/$+$T5/KU]3PJL/9S<0(R,'D5]7?LU^/_\ A(O"[:'=REK_
M $SA"QY>$_=/N0<CZ8KY1KH_A[XPG\">+K#5XG98HVV7"+T>(_>!_G]0*G'8
M?ZS1<5NM4.C4]G._0^\**KV-]#J5E!=VT@E@F02(XZ%2,BK%?G^VC/<"BBBD
M 5\T?M0?$+[;?0>%;*7,5N1->[3U?^%#]!S^/M7N?Q#\8P> _"5]J\V&:)=L
M,9_CD/"K^=?#&H:A<:K?W%[=/YMS<2-+(_JQ.3^%?0Y3A?:3=:6RV]3AQ53E
M7(NI7HHJ6TM)M0NX+6W0R7$[K'&@ZLQ. *^OV/+/7?V:_ 7_  D?BMM;NH\V
M.E$-'D</.?N_]\]:^L:YCX;^#(/ ?A&QTF+YI$7?/)CEY#RQ_.NGK\_QV(^L
MUG);+1'MT:?LX6ZA1117GFY!?7D&FV<]W=2K!;6\;2RRN<!$49)/L #7X1_M
M*?%RX^-_QJ\3>*I&;[)+<&VL8V;<([:,E4 ..AY;_@5?I[_P44^-3?"GX!WF
MEZ?=?9]=\3/_ &;;F.3;(D)&9I .X"X4_P#72OQT50JA0, # %?2971M%U7U
MT1Y>,J:J"%KZ/^%?[*-S\0OV5_'OQ,$4QU+39@=*4/\ )+!"<W)VCDM]Y1]*
M^?=#T2]\3:YIVCZ; USJ&H7$=K;PKUDD=@JJ/?)K]Z_A+\,-/^&/PGT#P7;Q
MJ]K86"6TI* ><Q7]XS#N6))/UKKQV)>'C'EW;_!&.'I>T;OL?@,.:7<RD,CM
M'(IW*ZG!4CD$>X->G_M,_"63X(_'#Q3X4$92Q@N/M%B>2#;2?/'SW(4@'WKS
M"O1C)3BI+9G*TXNS/V__ &,?C(/C;^S_ .'=9GD#ZK9I_9FH@9XGB &<GJ2I
M1B?4FO<:_)K_ ()A?&3_ (0?XQW?@N]FVZ;XJB @#9.V[B!9 .RAE+Y/<A:_
M66OC<91]C6:6SU1[E"I[2"84445PG0%%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%5=3U&'2=/GN[AML4*EF-&Q4
M8N345NSBOBQXF.FZ:NF0/BXNAF0CJL?_ ->O'JNZWJTVN:I<7TWWYFR%_NKV
M'X"J5>)5J>TE<_4,!A%@Z"I]=WZA3)H4N(7BD4/&XVLI[@T^BLCT=M4>/:YI
M+Z+J4ULWW0<HW]Y3T-4*]-\;:&=5TWSXES<V_P PQU9>XKS*O!KT_9SMT/N<
M%B/K-)2>ZW"BBBL#O"BBB@ HHHH *]>_9S^'?_"4>)#K5Y#NTS36RFX?+)-V
M'OMZG\*\LTC2;G7M4M-.LT,EU=2"*-0,\GO^'7\*^YO OA&V\#^%['1[;!$"
M?O) /]9(>6;\_P!,5ZV78;VU3GEM'\SXCBK-?J.$]A3?OU-/1=7^B_X!OT44
M5]>?A9!?6<6H6<UM.NZ*52K#V->#ZYI,FAZK<64O)C;Y6_O*>AKW^N+^)?AW
M^TM-%_"N;BU'S8_B3O\ EUKNPM7V<^5[,\7-,+[>E[2/Q1_(\EHHHKW3XD**
M** "BBB@ HHJ2W@:YF2)!EF.!2'OHC6\-Z?YTQN''R1G"^YKIJBM;9;2W2)!
MPHJ6N"<N9W/>HT_9PY0I\,SV\R2QG#H<@TRBH-ST33;U=0LXYUXW#D>A[BK5
M<7X8U/['>>0YQ%-Q]&KM*\RI#DE8^BH5?:POU"BBBLCH"OQ5_;^\6)XN_:M\
M8RQQF(:=Y.ED$YRT*X+?CFOVJK\(OVJ[C[5^TQ\4)000VO7&,=.HKV\JC>K)
M^1P8Q^XD>65Z1^S;X'B^(_QZ\">'KB.62SN]4B-QY2Y*QIER3[94?G7F]?5?
M_!,F)9/VK+ LH;9HUZRY&<']V,_K7T&(DX4I271,\VFN::1^PBJ$4*H"J!@
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M(FC?$.QAVV6NQ?8[TKVN8Q\K8[ IW[FHRNMRU'3>S_,K%PYH\RZ'PO7Z(_\
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MC)Z D!3[$UZQ17Q$9RC)36Z/><4URL_G1EADMII(9E*31.8W4C&&!P1^8IA
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M$0_:]/;.-MS'\T?X$C!'?-?B_P#\+H^(G_0_^*/_  <7'_Q='_"Z/B)_T/\
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M&=5JST/Q HK]O_\ AB#X$?\ 1,=#_P"_;_\ Q5'_  Q!\"/^B8Z'_P!^W_\
MBJ]'^U:7\K_ YOJ<^Z/Q HK]O9/V'?@3)&R?\*ST5-P(W*C@CW!W=:_(#X\_
M"^Z^#/Q>\3^$;E<)87;?9FY(>W;YXB">OR,H/N#77AL93Q+<8JS1A5H2I)-G
MG[*)%*L,@C!%?M+^P7\:O^%R_ #23=S^;KNAXTN_#-EF*#$<A'8,HX^AK\7*
M^L/^";OQK'PP^.B^'KZ;R]%\6(+-MS[4CNAS"^,<DG]V/]^IS"C[:BVMUJ/#
MU.2IY,_8"BBBOCCW HHHH **** "BBB@ KRS]J3PK;>-/V>_'FDW;I%%+I<K
MB1Q]QD&\$>AROZUZG7RS_P %$OC-IGPW^ .KZ UR/[?\3QFQLK>-\2*F09)3
M_LJ!CWSQWK?#QE*K%1WN9U&HP;9^.<;;XU;&,C-.I.G%+7WA\\?KU_P2]8M^
MRO:9).-9OP,_]=!7UM7S#_P3A\,7'AG]E7P\;C_F)7-SJ,7'_+.1\K_*OIZO
MAL4[UYM=V>_1_AQ] HHHKE-@HHHH **** /D_P#X*::'::I^R_J%W-%&US8:
MA:RV\S*-R$OM8*>V0<5^/]?IO_P53^-&GV/@C2OAG9SQ7&K:C<1ZA?1J_P U
MM!&<QYQT+-V/..:_,BOKLMC*-#7JSQ<4TZF@V3F-A[5^Z'['MU)??LR?#N:9
MM\C:6H)^C,!^@K\+;AO+@D;^ZI/Z5^]_[.OAO_A$?@5X%TK<'\C2;=MR]/G0
M/_[-7/FS_=Q7F:8/XF>BUYC^TI\78/@?\%_$OBR1@+JVMS%9*1G=<O\ +$",
M]-Q&?8&O3J_,;_@JM\9FU?Q=H7PVL9O]%TN,:EJ"@=9G!$2YSR I8D>N*\7"
M4?;UE'IU.^M4]G!L^#+J[FO[J>ZN9&EN)Y&ED=CDLS'))/XU$S!5))P!R:6N
M[^!?PPN?C)\7/#'A"V#!-0O$%S(J;Q% IW2,1Z8&/QK[64E%.3V1X23;LC]0
M?^";7P9/PU^ \.OWT'EZUXID^W2;X]KQVX^6%"<\C&7!_P"FE=!_P4"^,7_"
MI?V=]8BM)FCUGQ 1I-GL(W+O!,CD?W0@*G'=Q7T3I.EVNAZ79Z=8PK;V5G"E
MO!"O1(T4*JCZ  5R'Q,^!W@/XR'3SXU\,67B/^S]_P!E^V!CY6_&[&".NT?E
M7Q7ME*O[6HM+W/=]FXT^2)^ ZJ$4*.@&!3J_;_\ X8@^!'_1,=#_ ._;_P#Q
M5'_#$'P(_P"B8Z'_ -^W_P#BJ]S^U:7\K_ \_P"IS[H_$"BOV_\ ^&(/@1_T
M3'0_^_;_ /Q58_B_]@SX+:UX6U:PTWP%I>DZA<6TD=O?6JLLL$A4[74ENH.*
M:S6E?X6'U.?='XL59TW4[K1=2L]1L9?)OK.9+B"3^[(C!E/Y@5/XB\/WOA/Q
M!J>B:E'Y6H:;<R6EPHZ"1&*MCVR*SZ]G1HX=C][/V??BM:_&KX/^&O%ULP\R
M^M5^TQ[@3'.O$BG'0Y&<>XKT2OS3_P""4WQH_L_6?$'PRU"YQ;W@.J:6LC@
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MQ$.>)RU*;I2Y6>V_L;?&3_A2'Q^\/ZS<3^1H]\_]FZF6;"B"0XWM[(V'_P"
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M -?UH>F^&,)F="%+%3DHIW232^_1_+U/T;_X;Y^$?_02U+_P7O1_PWS\(_\
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M **** /S5_;;_8<\;>-?C9=^*_A_HB:CI^M0K/>K]H"%+I?E8X/0%0G3OFO
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MF>"T445U'ZX%%%% !1110 4444 %9^O:J-(T]YNLI^6-??UK0_05YWXHU?\
MM342$;-O#\J>A]3515V=>&H^VG9[(QV9I&9F.68Y)]ZI:QID>KZ?);2<%AE6
M_NMV-7**N<(U(N$E=,^F6FQX_-$]O,\4@VR(Q5A[BF5V/CK1\,FHQ+P?DFQ^
MAKCJ_,<7AY86M*E+Y>AZ4)<RN%%%%<984444 %%%% !112JK.P51N9C@*.Y/
M04".A\"^&SXDUV.-P?LD/[R8^W8?B?ZU[LJA5 484#  ["L#P1X;'AK0XH6
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MS?\ !4KP;X1N;G3O FDR^,;V/Y1?RMY%EN!P0#]YACD,HP<UX_\ \/</&O\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M:SBO(E?[RJZAL'W&<'Z5_/:J[4"^@Q7[+_\ !.+4Y]3_ &3_  P9W,C0W%W
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MKPS>Z/\ M/7&JW$)2SUC2[9[60]'\I=CX^AQ7!AZ4:>.E'ML=%2;EATSQO\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH ^5_VBOA^/#?B--:LXMMAJ1)DQT2;
MO] W7ZYKR&ONGQMX5MO&GAF^TFY VSI\C?W''W6'T-?$6L:3=:#JMUIUZGEW
M5K(8Y%[9'<>QZCZUUTY75C]JX8S3Z[A?85'[]/3U71_H4Z**R_$FK#2=.=E/
M[^3Y(QW^OX5J?;0BYR45U.8\9:Q]LO/LL;9AAZXZ%N_Y5SM&2<DG)[T5NM#Z
MFG35."@@HHHIF@4444 %%%% !7 >-M'^PWHNXEQ#.?F]G_\ KUW]5M2L$U.Q
MFMI.D@P#Z'L:\['X58N@X==UZFD)<KN>2T5+=6LEE<RV\HVR1MM85%7YHTXN
MSW/1"O:OAKX:.A:+]HG7;=W>';U5/X5_K7GWP]\,_P#"0ZV'E7-G:XDD]&/9
M?\]J]OK]!X7R[5XVHO*/ZO\ 3[S\9X]SJR65T7V<_P!%^K^04445^C'XL%%%
M% !1110 4444 :=G<&:/#'YEXJQ61#*89 W;O6LK!E!'(-=,)75CYK&T/93Y
MELQ:**]'^!?P[/CSQC')<Q[M)T\B:XW#AV_A3\3U]J56K&C!U);(X8Q<FHH]
MS_9X^'9\(>%?[2O(MFIZF!(P(YCBZHO]?QKUFD P,#@4M?G5:K*O4=26[/=A
M%0BHH****Q+"BBB@ KY4_; _88TO]HVX7Q)HM]'H/C2&$1&>1-T%ZBCY5EQR
M#T ;G [&OJNOEWXU?MZ^&?@'\7[KP9XIT'49+1+6&XBU+3BLI+/U#1DK@ =P
M3]*ZL/[;GO1W,:O)RVJ;'PAK7_!-_P"-^CW!B31M/U,#_EI8WH93_P!]!3^E
M9;?\$^?CFJD_\(DIP,X%U'D_K7Z2:'^WM\"M<C4Q^/;2VE(R8;JWF1E]C\F/
MUK>O?VPO@QI]F;F;XAZ0(0,DJ[L?R"DUZOUW&+1P_!G'["@]I?B?B7XP\&ZY
M\/\ Q)>Z!XCTRXT?6+-ML]I<KAEXR"#T((Z$$BOKO_@ES\7]2\-_&2X\ /)+
M/HGB&VEN(X"_R6]Q$I<R '^\H*X&.3FO(_VV?C-H/QV^/5_XD\,M++HT5E!8
M0W$J;?/\LN3(H/(4[^,\\5T7_!.'1;O5OVL?#EQ!!));V%I=SW,J+E8E,+*I
M8]@6('U->I6_>85NHK.WXG)3]VLE%]3U3_@K?;R_\+1\ 7'EMY']CSQ^9CY=
MWG@XSZXKY=_9D\067A3]HGX<ZOJ4OD6-IK4+S2?W0<KG\V%?I/\ \%+?@Q>?
M$KX)PZ_I4+W&I>%IS>M!$@+26[+ME]_E'S8&<XK\C%<JRNC%&4AE9>JD'((]
MP:RP,E5PO)ZHO$)PJ\Q_1A17P#^S%_P4O\-R>%].\._%-Y=(U6RA$ UV.-I+
M>Y10 K2 999".N 02">*^CE_;;^!S6XF'Q$TSRS_ +$N?RV9KYRIA:U.7*XL
M]2-:$E=,]PKYE_X*/?\ )HOB_P#ZZV?_ *4QUTWA3]M?X1>//'.D>$O#/B;^
MW-9U.5HH4M;:0("%+$LSJO& :YG_ (*/?\FB^+_^NMG_ .E,=.A3G3KTU-6U
M7YBJ24J<N5W/QFF_U,G^Z?Y5^]'[,_\ R;Q\-?\ L7K'_P!$)7X+S?ZF3_=/
M\J_>C]F?_DWCX:_]B]8_^B$KVLV_AQ]3AP?Q,_)+]NRP;3?VL/'T+'=NGAE!
MQCAX4;^M<;\"_@+XE_:(\677ASPK-I\6I6]JUXPU*=HD,895."%;)RP[5]8_
M\%4_@K=:7XPT;XF6%L#IFH1+IVHN@YCN%_U;M[,N%'NIKY'^!/QHUOX _$G3
MO&&AJLTUN&BN+20X2Z@;[\;'MG .>Q -=U"<JF&3I;V_%'/4BHU6I[7/?O\
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M_0F-D!;!ZX(XSC)ZU[V,J8BG9T5='GT8TI751V/EC_AUI\:/^?KPM_X,)?\
MXU1_PZT^-'_/UX6_\&$O_P :K]!%_;8^"#1"0?$32]A./NRY_+96/JO_  4
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %> ?M,?#T20Q>*[*/YX\17JKW7^%_P .A/TKW^JVHZ?!JUA<6=U&);>=
M#'(A[@C%5&7*[GJ99CYY;BH8B/3==UU7]=3X")"@DG '))KS;Q%JYU?4&<<0
MQ_)&/;U_&O6?C!X$UWP?JUYHMGIUY=HSGRI[>)G!A/3D=^WX&O*_^$)\0_\
M0"U'_P !F_PKT86W/Z8RVKAZE-8A35I;:K8QJ*V?^$*\0_\ 0"U'_P !F_PH
M_P"$*\0_] +4?_ 9O\*TNCVOK%'^=?>C&HK9_P"$*\0_] +4?_ 9O\*/^$*\
M0_\ 0"U'_P !F_PHN@^L4?YU]Z,:BMG_ (0KQ#_T M1_\!F_PH_X0KQ#_P!
M+4?_  &;_"BZ#ZQ1_G7WHQJ*V?\ A"O$/_0"U'_P&;_"C_A"O$/_ $ M1_\
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M/<YC*HK5_P"$3US_ * U]_WX:C_A$]<_Z U]_P!^&HYH]P,JBM7_ (1/7/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
3 **** "BBB@ HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>sava-20221103.xsd
<DESCRIPTION>EX-101.SCH
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--XBRL document created by Certent Disclosure Management 22.2.0.1 -->
<!--Based on XBRL 2.1-->
<!--Created on: 11/3/2022 8:09:39 AM-->
<!--Modified on: 11/3/2022 8:09:39 AM-->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" targetNamespace="http://www.cassavasciences.com/20221103" elementFormDefault="qualified" attributeFormDefault="unqualified" xmlns:invest="http://xbrl.sec.gov/invest/2013-01-31" xmlns:sava="http://www.cassavasciences.com/20221103" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:currency="http://xbrl.sec.gov/currency/2022" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:exch="http://xbrl.sec.gov/exch/2022" xmlns:stpr="http://xbrl.sec.gov/stpr/2022" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:us-types="http://fasb.org/us-types/2022">
  <annotation>
    <appinfo><link:roleType roleURI="http://www.cassavasciences.com/role/DocumentDocumentAndEntityInformation" id="DocumentDocumentAndEntityInformation"><link:definition>00090 - Document - Document And Entity Information</link:definition><link:usedOn>link:presentationLink</link:usedOn><link:usedOn>link:calculationLink</link:usedOn><link:usedOn>link:definitionLink</link:usedOn></link:roleType><link:linkbaseRef xlink:type="simple" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:href="sava-20221103_lab.xml" xlink:title="Label Links, all"></link:linkbaseRef><link:linkbaseRef xlink:type="simple" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:href="sava-20221103_pre.xml" xlink:title="Presentation Links, all"></link:linkbaseRef></appinfo></annotation>
  <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"></import>
  <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"></import>
  <import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"></import>
  <import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"></import>
  <import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd"></import></schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>sava-20221103_lab.xml
<DESCRIPTION>EX-101.LAB
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--XBRL document created by Certent Disclosure Management 22.2.0.1 -->
<!--Based on XBRL 2.1-->
<!--Created on: 11/3/2022 8:09:39 AM-->
<!--Modified on: 11/3/2022 8:09:39 AM-->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Document And Entity Information [Abstract]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="dei_DocumentType"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</label></labelLink></linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>sava-20221103_pre.xml
<DESCRIPTION>EX-101.PRE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--XBRL document created by Certent Disclosure Management 22.2.0.1 -->
<!--Based on XBRL 2.1-->
<!--Created on: 11/3/2022 8:09:39 AM-->
<!--Modified on: 11/3/2022 8:09:39 AM-->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="sava-20221103.xsd#DocumentDocumentAndEntityInformation" roleURI="http://www.cassavasciences.com/role/DocumentDocumentAndEntityInformation"></roleRef>
  <presentationLink xlink:role="http://www.cassavasciences.com/role/DocumentDocumentAndEntityInformation" xlink:type="extended" xlink:title="00090 - Document - Document And Entity Information">
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="dei_DocumentType_638030597791162047"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType_638030597791162047" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag_638030597791191971"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag_638030597791191971" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate_638030597791191971"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate_638030597791191971" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName_638030597791191971"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName_638030597791191971" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode_638030597791191971"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode_638030597791191971" order="5" use="optional"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber_638030597791191971"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber_638030597791191971" order="6" use="optional"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber_638030597791191971"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber_638030597791191971" order="7" use="optional"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1_638030597791191971"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1_638030597791191971" order="8" use="optional"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2_638030597791191971"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine2_638030597791191971" order="9" use="optional"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown_638030597791191971"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown_638030597791191971" order="10" use="optional"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince_638030597791191971"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince_638030597791191971" order="11" use="optional"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode_638030597791191971"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode_638030597791191971" order="12" use="optional"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode_638030597791191971"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode_638030597791191971" order="13" use="optional"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber_638030597791191971"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber_638030597791191971" order="14" use="optional"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications_638030597791191971"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications_638030597791191971" order="15" use="optional"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial_638030597791191971"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial_638030597791191971" order="16" use="optional"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer_638030597791191971"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer_638030597791191971" order="17" use="optional"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer_638030597791191971"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer_638030597791191971" order="18" use="optional"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle_638030597791191971"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle_638030597791191971" order="19" use="optional"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol_638030597791191971"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol_638030597791191971" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName_638030597791191971"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName_638030597791191971" order="21" use="optional"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany_638030597791191971"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany_638030597791191971" order="22" use="optional"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey_638030597791191971"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey_638030597791191971" order="23" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc></presentationLink></linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139957531997296">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document And Entity Information<br></strong></div></th>
<th class="th"><div>Nov. 03, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Document And Entity Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Nov.  03,  2022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Cassava Sciences, Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-29959<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">91-1911336<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">6801 N Capital of Texas Highway<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Building 1; Suite 300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Austin<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">TX<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">78731<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">512<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">501-2444<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.001 par value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">SAVA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001069530<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>sava-20221103x8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="sava-20221103.xsd" xlink:type="simple"/>
    <context id="Duration_11_3_2022_To_11_3_2022">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
        </entity>
        <period>
            <startDate>2022-11-03</startDate>
            <endDate>2022-11-03</endDate>
        </period>
    </context>
    <dei:AmendmentFlag
      contextRef="Duration_11_3_2022_To_11_3_2022"
      id="ct-nonNumeric-2c33e160-aa46-4435-877b-45aff889e3f8">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="Duration_11_3_2022_To_11_3_2022"
      id="ct-nonNumeric-d2f9fc00-a827-4873-8c15-8cdd589cf83d">0001069530</dei:EntityCentralIndexKey>
    <dei:DocumentType
      contextRef="Duration_11_3_2022_To_11_3_2022"
      id="ct-nonNumeric-e67d0746-7966-4968-894b-be4ee28da319">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="Duration_11_3_2022_To_11_3_2022"
      id="ct-nonNumeric-14b54c8c-847b-46e6-b4f1-82c0d9450db3">2022-11-03</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="Duration_11_3_2022_To_11_3_2022"
      id="ct-nonNumeric-d0e2577d-902e-4adc-a243-d6fa3737ce5c">Cassava Sciences, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="Duration_11_3_2022_To_11_3_2022"
      id="ct-nonNumeric-9c983e58-a8da-4469-b1c8-52f956560b30">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="Duration_11_3_2022_To_11_3_2022"
      id="ct-nonNumeric-7ab3e5db-9430-4de8-ba6c-4ace80dfc6f2">000-29959</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="Duration_11_3_2022_To_11_3_2022"
      id="ct-nonNumeric-df940cc1-4c78-409e-aa67-63a9802095ca">91-1911336</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="Duration_11_3_2022_To_11_3_2022"
      id="ct-nonNumeric-21f39458-1ff8-4c5a-9834-6f049f75da26">6801 N Capital of Texas Highway</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="Duration_11_3_2022_To_11_3_2022"
      id="ct-nonNumeric-743b86ac-ce23-49fb-a285-dc53d2d3ae3d">Building 1; Suite 300</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="Duration_11_3_2022_To_11_3_2022"
      id="ct-nonNumeric-9ec22fa6-f456-4358-9e74-79a796bd2364">Austin</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="Duration_11_3_2022_To_11_3_2022"
      id="ct-nonNumeric-feeaac54-b06a-4cba-8f45-20b269d7e228">TX</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="Duration_11_3_2022_To_11_3_2022"
      id="ct-nonNumeric-c8247d0a-97ca-42ff-8328-7ba885f4753b">78731</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="Duration_11_3_2022_To_11_3_2022"
      id="ct-nonNumeric-a17f4c40-84fb-4597-b51f-ecce98652cfd">512</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="Duration_11_3_2022_To_11_3_2022"
      id="ct-nonNumeric-8542bf50-13c7-4dc2-bc74-6031aa89f2c3">501-2444</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="Duration_11_3_2022_To_11_3_2022"
      id="ct-nonNumeric-93a0ec63-23eb-4e73-b231-2d507aa25db6">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="Duration_11_3_2022_To_11_3_2022"
      id="ct-nonNumeric-71295f04-bf0a-49d1-9b15-84617a86de06">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="Duration_11_3_2022_To_11_3_2022"
      id="ct-nonNumeric-be033387-c4c4-4c43-9c87-eb1de48e0da3">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="Duration_11_3_2022_To_11_3_2022"
      id="ct-nonNumeric-b2985afa-82eb-4a65-bfeb-2250af63c1c7">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="Duration_11_3_2022_To_11_3_2022"
      id="ct-nonNumeric-768fc76d-72fb-4427-aa72-266a493223e2">Common Stock, $0.001 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="Duration_11_3_2022_To_11_3_2022"
      id="ct-nonNumeric-28121358-624f-416d-9fd8-76144d7e8b8d">SAVA</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="Duration_11_3_2022_To_11_3_2022"
      id="ct-nonNumeric-921c9cf2-d1d8-4ca7-8703-861d0fbaddc5">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="Duration_11_3_2022_To_11_3_2022"
      id="ct-nonNumeric-8f49d2c8-9e86-469c-9fa0-aec4307a8bdf">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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M#RP/9'I;K?%NXQ/R^AQ@/7UM0K"=XI.([12O-2#QNH%'GL>[C>4!#ZP+V.Q
M_G@>F*FX3YI"5S%NV G&D3S'$)C%^(QF&5*=##[Q_F"G)$WS/(X %F>0IA@"
MIQ%', ;  4/2='@//GL?)=-[*CG_5U/\!%!+ P04    " !"2V-5EXJ[',
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MA1H#V#<YD 27Y*IU5%WI>:;7-Y-;2>C@W(-@[^&5C!W-CQ]W]P-02P,$%
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MO-9.&G_FB^$_7G\!4$L! A0#%     @ 0DMC50=!36*!    L0   !
M         ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " !"2V-5
M\QW^;NT    K @  $0              @ &O    9&]C4')O<',O8V]R92YX
M;6Q02P$"% ,4    " !"2V-5F5R<(Q &  "<)P  $P              @ '+
M 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( $)+8U544V!R<P0
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M2P$"% ,4    " !"2V-5)!Z;HJT   #X 0  &@              @ 'G$0
M>&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    " !"2V-599!Y
MDAD!  #/ P  $P              @ ',$@  6T-O;G1E;G1?5'EP97-=+GAM
7;%!+!08     "0 ) #X"   6%      !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.2.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="sava-20221103x8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00090 - Document - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cassavasciences.com/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document And Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="sava-20221103x8k.htm">sava-20221103x8k.htm</File>
    <File>sava-20221103.xsd</File>
    <File>sava-20221103_lab.xml</File>
    <File>sava-20221103_pre.xml</File>
    <File>sava-20221103xex99_1.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "sava-20221103x8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "sava-20221103x8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "sava-20221103_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "sava-20221103_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "sava-20221103.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 24,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 23,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "sava",
   "nsuri": "http://www.cassavasciences.com/20221103",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sava-20221103x8k.htm",
      "contextRef": "Duration_11_3_2022_To_11_3_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00090 - Document - Document And Entity Information",
     "role": "http://www.cassavasciences.com/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document And Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sava-20221103x8k.htm",
      "contextRef": "Duration_11_3_2022_To_11_3_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cassavasciences.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cassavasciences.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Document And Entity Information [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cassavasciences.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cassavasciences.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cassavasciences.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cassavasciences.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cassavasciences.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cassavasciences.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cassavasciences.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cassavasciences.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cassavasciences.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cassavasciences.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cassavasciences.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cassavasciences.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cassavasciences.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cassavasciences.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cassavasciences.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cassavasciences.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cassavasciences.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cassavasciences.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cassavasciences.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cassavasciences.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cassavasciences.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001069530-22-000056-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001069530-22-000056-xbrl.zip
M4$L#!!0    ( $)+8U6O&"(/ 0,  &L*   1    <V%V82TR,#(R,3$P,RYX
M<V3-5<N.VR 4W5?J/U"O:V,[&FEB)1G-HY5&2MIJVDJSJPC&"2H&%W >?U_
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M96Y-LZKYI# E:RI1>GDVCNW97I*T(/CD"O&;AMC[:]*YOE&_XR&.P2UFB.W
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M^YYCC=O^I^3$,-7-I4!IFST-=+N$=,[A^X.2#5OP,705X)UU2\ZL=KJ_6=D
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MLD"OWT)0M(Z*"LGH%"")F(>%$6*-GXLB YV,A&Q2R)*$C0E_=B)"T_6MWZ2
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M%ZD$)H7AI3!W#&&B^2 S\)71!4: C07/F@LQ*!]J31\J0PUN[YMY;%N!Z57
M=+($&.B1V=\G]_]2W-XM[UZ8[3>T?&90^<4'S\&6XX,"$1(-$TXM4W.)%[#P
M749O*? ^GPG#%=PFT_LN),KH7O+"/A ?CSG-@?B2M(@F&&6\* 5@K%(D0LDL
M*@.GH"TID_ KWA6/Y<NO(WBU'#D)-!NN"'X597 ?T"E)J$PG0"A-1TF18B#+
M2<*(8%F9')$M"V4P=\@TE&&6)]O/C'I9)\XMU]B_A_?Y4($-+D75WRIK5W&\
M=1U<"^SP5[00C+>GJ]N*O&3%[6,@4.=0)AG7G*<&HSV^!D]QE\E>^NM?D)S"
MBPZ3 [#8BB4[*@7EJ0M/)B![4?]!\FS?51-&4E],^F5(+OG/@I/OTTZH'J5[
MPQS)&B#0IF0I',AB>S =C?@^NCV#29C+X"H27Y-QMM\"3,YV?)\3-M_Q917N
M@:7N>'A/]G^=L]L_ZL-1FQ:8_31I/7H"IFF<PMBJ-)7]M]C8<9KS 7+;FMY&
MY_QR%)<A_)^.T7&4T3C-1H(_5RE\FU6=VCK2G,>B(B#T.Y@<HX0!-#X5?_L;
M0LIJ.1\!8(?31.R533[]#,JP^%:6 'N'@(T3R<PK3.X0.DNON/PL"C)WD;2O
M"\]1GA.PG!B2B2?SM)S(B/39]*,@RI'OMW4P>EB93)ZF8IB"S5Z5CQ)I> D>
MPN^$\C?SV+RSWK^ /H^2TC=26*L3"Q/ZHW"A=4="R&P@Y\47+V37!5P:I>%(
M)%$F>UOV:-8G<5Q8PP%'C(.1S9#$D 'MBF+.BM_Z?F$%2YB!_3I,,UY\A6UJ
MOWJ/]/?M2M<C&926]HZ\H7K5;.'JC1]VI7F=2E_G-5C8*!L%_X+W2;M9WAA'
M)(CB\E7%RTD^J4\;]4:T/R><N5;.(7@6NO)#"6EAW%>?0EB:6+5RBLZVIZCN
M70-^5[H?B&!Q]=TZ^>S;U\N:S;T_AOM&H.O)/LQD&\IZ/#2D%F&T5MK*LV??
M#6DJVRO MU!?_$)]^31UB!5?D)6)B;*"<:I))6LO\1ZI1!,;#HP<1 P(:MI>
MJVVHP,AW&2%[!PAM5^% X0!YBA#6&2F]R7UM&V;Z&G@'Z^ $KLVVQLWRN^K]
M.O?^VEE==7]-)X$[T;H*!Z]K!!="8YQ6#IZ]THDD)2"W854.U?)KZ4W@"35+
MO*]9XD[<F&*'#;+#,<^HB(;R@II#:H:2;8]Y>W>LO^T=^OZ(?(T]JMCWS;JV
MM@OP<E-$/8>^XG+%Y77M48+Z0D;]9.2*8+G_2-<U\X;?^/XWO=W/!Z_""2]8
MOG\)?E8J]U^+_5CG\_NQ@C'JDDS* O5H)/> 9+OH-*'M13NUIM@D:F:J _74
M=F;2-:N>/*8F)C4Q-;=':SO>NS!1"/15;AP\E:$ A.;1%4?')"?H4Q1SM"/G
M$28W7<KPQ6*#J"PJ18G^_/G\=\12.I([M#;YG;>M'9Y*/O?D\_+HN5?G4!4^
MI\+G5/C<.Z7 V?'RKU&61^%8R6Q-'+/Y1;;68>_TE[.CBS_.3]Z-@)L>T_E2
M@15&18W7_+_.Y/THTY+\>Q2)*BSBZ=%3NXMRF[!1/$:4C&0^DB($3)2A7_#*
M@*,,Y%2& $:YC 7KDSB4#BCYH,)15160$5=\)".ABN>14=Y/!8B!-2H7TPNP
MH8;2FXMK)ASH[F9V%1ZTX6B F1S]IM>V52C NXP)F4&!JP*#% A,5U&!0H'N
MM$V%@C5M*FH>'%;I!TK=?9@40"F5)P]:1FM+$&'935\2E"ENO_T:?_<,WW!U
M;;[VLYL]"F%*E_&SLC/U2)(5#WI5/UCWJ">_"X)ZW=.3L^Y);Q>=GG7;[W,^
MJA6ZFN2Z>F946_/0HZ8O-7UMV_150SXAZ)C'Y)H(CF8R8:E)Z<TQ4T=:4;-,
M$^%0%QUE:T"SPN>Z+9A9IV:R'2!8Y7-5*'@O*%#JQ"NK$S/;NHLJ[3<<($K!
M6(."<4QRN \M#\K:.IY1*H>:;)3*H5"@5 [EP5 *AO)@*'6B=ICY>;RWO8!Y
M#ZI'G1)4=+(..CD_[:+_;J->]]<O)V?;BRVET"B%1BDT2J%1"HVRC)624C?F
M.!$1+;00VD^YVAC2:/ H+41I(4H+45I('2ED:T"@M)!U9%7K1SR<^8SEES",
MZ.,_VM$\%"EUY*7JB,J3]\"86I6"365?JYF>5*8^"U(VAG_Z^2 ^_']02P,$
M%     @ 0DMC50R::3E>$@  *WT  !@   !S879A+3(P,C(Q,3 S>&5X.3E?
M,2YH=&WM/>]7&SF2G^?>V_]!1V[GDG>VL4W(#H;A+>.$V\P1EA>R=Q_WR=UE
MMX9NJ4=2VSA__55)W7;;& 8L.T"6S.,-N-52J52_554^^O=F\V]?/IVQ6$5%
M!M*R2 .W$+.)L GK@[;TX7MAHE290@/[Q"4?@1O:[;:ZK7:KTVP>_^G?CG"F
M?OFNDCW6Z>SN[7;;W2[[J==I]SI[[.23'YC8+,7__W"4 (_IEQ^.K+ IN%]_
M^'"=B(&P[."@PYKL#$8\97V5Y2D7TKK!N[/11[O5%$<#%4^/CV(Q9L9.4_AY
M)^-Z)&0SA:'M_:6;V\/R RU&2?G)SL(+$Q';!$%M_WD'9W0KY8N3]=KXDH5K
MV^2I&,E>A$@ ?3A4TC:'/!/IM/=%9&#8.4S89Y5QZ9\9\140(;AD-?,//\J!
MR0_+979S]_'1+D)SO+V%<=DCSB3/<-Y__BV]>O?VH-M^MX]8V.7'1_1"M6HL
M#.)[VF-"ID("(4ID(V9T]/..X6/>I'/M=-I[UW!]</#/SJC=[K1^RT<[B[AD
M^ZVW[8/.NXZ0ARP!AWC6:?WEW4_=]IZ0.XRG]N>="Q%9(JP. 4)0',^1LAH5
MC'[V%E'BCO7>&'D[Q\A=^ZY/U\=U!EKXSR9^,P.5QK5Y:5K$U9R"6YV '3WL
MD+O=AV_IDDO#K5#RKDUU/:?TN:&39Y>1 !F!*3>VE;4\<VQSA5.1(B*WN<(9
MGY@"B6";:YR,4"::[:YQ 3H'J[E5>JMGSM3P>9/4CZ^NN^U.__ R4=HR+F-2
MFH@UZQ^\/V1]GN4<.?N>,B% X&]5O"V@\B&;^*TP5@RG_J/RCYZ@C35%#&JD
M>9ZLH]."M^@.[_3#Z>F]=T5S-TN-UMEO__F9;//D'Y=?/IXWV!>XYH9YPMP[
M?+#\N&.%<S6&; !Z@U.NQ[IW3+BWP;D:&YR+==L;G*W[%.;"30536;CM,9^I
MP3[*J,5>GW,3\]][ 3!=GOSOR9L&XP%31/A,1#QM&HL>5<!$ Z$L1(E4J1I-
M0P!"-XO+:8-9%?.0B;B4JL"3BM>?(HSK=XYMPA]N&,U?%_;Q0$]X (6S(9JV
M<1!=IMYT#8!!R) -0 P:G?Y(%3KD"/F:UG&-'T!;G".$C"2Z]"(N>&K8)%$!
M,\$U1(4-/-G*1C4S&S5>LE&CTD;= -YM BYP@Q)E_<E:+)2;OB 8:*+]%\M)
MR$95)(GQ-(41VEU.4!"L[V$(,N;2&H^-@T/"CI!#I3/G!,R0$T#<$2_,8XI%
M'HS/7$,D<F%5$2*E8B#M!SB*+6OW&?:1,J,KEFL108#&?\ZXSHK4BN9 I"F2
MW^-M)%9IRM<VZ3>P_IQ80C3ZPP,^M9/@^@HLLB]2/G[XU0F$ -KRPA=P((KT
MFJ2LB!_5A=)7M.,8QI"J7,@1BGY+ 787>T>IQ$[2K^B#9J#G;^'JP$T O[0V
M=,S?A0O]?08&O$XLK;Q*#_9891RL3P!S#<IP-)K_+ =ME$1C#B2*\<11KAJ#
M9L8+^X;_BQ@@ 9[:A*DA*FJ+#ZUI.":9#;"ZL$FKIJ:9X1,<PE2>HPE32&&G
MZ+DPQ)3(BY1;0(:IZ1 WVU!(+B.!FYZR 4@8(@:&6F6T@M#!IM5/AP%*T1EE
MN3*"9$O /)4T")!.@RG*'?K829W2+UP41;$N1DX*Y:#R%/Q]X>T2J>'F07/8
M65+.Z.+#82HB/,?,*SA#AQ]@F#@X0DS-.FD!LEGLX:S3%])0 RUY]+%*DB9D
M(.UD!M(Q(,EZ X\)K2'GF@]P8,)U1H1)1#QSL4D=<6LAR_$7?(B$&=\0\/3&
M''\XH&(--N&(2#DJ1Y$%6[W86F7($N:+R#)AD.JG^ <S"<]@6*0M]M%]O#[>
M"HFBA&:JG(CO2U9^OQI@[@OAXA)A$;B6$[?K$T.GT6ZW ]X?HJ<,I7&$#^G:
M:8HSH##/'-UG/ :23HL.&]E)IAADPA@G1TIF^T?KLL5.E8K]=0P)K),891KZ
MO-I[=!PY"=*4S:+A_4/D6^1V,_.('=MI,+B\>R>$50*#4G7]6@Q281*7:T%O
M!,AZ]8B6O0JQZ(TB1<XRB 5OL9,H4CIVXG@N:AUY-S9KVAAN"^W27&@5[QB@
M/)<H_NF2M#$+8/$1FCB"E(+%1P09JG:HS!I\61NO-;WML9+TD?T-Q2WX0!6V
M<I47-%4L8B:512TSIK>G#!5!BH?*Q@A\3)(_ BW+E<H)O/H9J@+G()K&%^8&
MF78/"62SL!#($4(2$Z]Y@$M$U",CA/M<*[*J!MPXZB13X8:S/S</:@9:B.OQ
M]%7/(DS5)G'4SSL=Y,)J[SCB*-'E@[U90DVD4J5[KP[<OQWF\FOP14I68@YL
M'.+NB"F))M''\UU3V*LY0**X:O(A#NCQ=,*G9LZ[^1I94+-\E0?B8</Y*31%
MSSGDT8IK(G_9,R.)>JK5,]I5=:/*]AJ,TJZ>^WXNUKGK>N :6Y[^P=>A3PO\
M==RLI[6#;W0 SY;'5L+_!^FE6U6)-S'PJ&D :"P9M)/H<@]ME%];[(,65ZRO
MI%1IBLZYRW$F@ZV?<#1TD%_(U#M#EWOD[9W_UJK(T7]GOX $$R7L5 N(4S3>
M4%#W%8(@V8]H$QVR$ZVD&@[9V=D%&4?H77A? HTL;TD)<FHLHK+%/N%/!80#
M,?4K(HQ&95#!D>*AH756F8G._D)#-S.E:48WI])J"C+(*"UB'Z_YCW>LO$A@
M/I[O7V+5==W)+WUG?"[<.33K0PT;X+:1/LBJ&T#"TR&!Q-E8.>NVEH-018RJ
MR4_5-5&#J9N^,P.QM";G3MX0%U63,K)"2J_M73E((:+MMM@3MO->0@Q+E\U!
M5[<:?1K\,:"%*@QY,P9^+QS[LTD"LHH^%@:6;VN1?SA#4Y?8#EFE# A'R_<L
MRQ'BC%^A5Z<D3"G.X&[**TIT0QM+OL8ZXL=P],R0VQ_/\:[$3-#-?'G >$SD
MN$8^.D*^J)(HP.JA]H12.6K77 [3P@5N9F[SH'!#\%EJ%'J4*#8X72 @4;JZ
ME%05Y6T 25"N4>H.@(XFQL-R3K^>UB*I 5&:60PV((Z%;C1'B:BUH!!P&<1M
ML2\4 4*13YS))J@;1B]AT\WL:J T*M_F0%FKLEX'K3))=/'J_0']Q[[%KDLG
MO>W^U23@_Y5"S*)2+2G>&1)(NRC#2!LR'ON;$4X#YCE#2$44F;44F4515*0Q
MTOQ,#2,*E+<@D%N !KL@D'$W#RCMEK1V+3$G:\SCF_6X6=T":7D9\^UT;7F"
M5N4KCF_+Q^L 0\PCMMUFZM5C]#?+Z83DJ"P?V^NT??W8"@'QP*G>+B;)T[ U
MK.-ETIN%D_X%SN[^-QY#D1*A.SL:N::Z J<8+IFFSC#%62&_,R]I+$9*DS42
M4W#4.+L<=1F@.4QJ+2A%)<2HL&BY).@2PL,K=>IJ_6-(YJ<WW4/N2&Y%>U#*
MFB%_+R4=' (;\O2T,@:7K,W2%!'&0(:&#_EL:#[.P^<U9VS]M/-5OO[Y)B=3
M@2EKJ^;\L,G)QG15&4%(IL"J:=]O<C)NU[<^5\WW::/ E<DQ1+,!^72KIK[<
MY&2>^S<*W\4F)Z/[U\BC,> 2<^MH%%F!2H]G 2+]]4DQ(F^E\Y._@'C3V.AV
M3]^?/%U6!DF6=Q\-\*\@V058G[ZTT?UO]+A3'U+;Y)R_;!2A5=3PR7*,R\)[
MLM!!FFZ47BC&G;J4LA )<0H#77 ]99WV5F3$4]<LOV[4!BLTA0&>KHR1\?HV
M]*H)_S4M6+M^-=C66:1P&:\;A:^_R<E\7.O%!]B,#]!MM_>?@Z$=HJ'>0^2S
M:+H=IZ$Z&]90GV$L8$(N_Z^E_$;J/(="JS*QCETF%!<Y5^Q#S8=]3W3R:>D\
MOM ]*A6&LPN>(\BG]3P]%!NW1DC.@)=IKGTN8X'O!.2%AMXPO9XE+KW="L:7
ML< ^5_$=SBX<T;#+ZDH9GXVX#W)_!LJ38R=4]<)#"RU"470)N:TG=X7@B-AZ
M_>#C/3%L<D7:'XFPAL  D%^O_VKIE0:TIMA?_]7RM.;)A2_Q]<>Z\'L4E+@A
M]2RL>]*LR^*^7 K*/#*JO@EUS/;,7AN1-8ND>?KQ[*S)LS=T&WZK1LNURK4
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M6]^W 5$>RFNFI&@-F1H_+=#PP+6P+M2XVO/YLJHS$0YUS22B*LAH?-XI;7(
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M4$L! A0#%     @ 0DMC5:1O!43@!0  T3L  !4              ( !, ,
M '-A=F$M,C R,C$Q,#-?;&%B+GAM;%!+ 0(4 Q0    ( $)+8U74[59AE@0
M (XJ   5              "  4,)  !S879A+3(P,C(Q,3 S7W!R92YX;6Q0
M2P$"% ,4    " !"2V-51Y,!P$ 5  "P0 $ %               @ $,#@
M<V%V82TR,#(R,3$P,W@X:RYH=&U02P$"% ,4    " !"2V-5#)II.5X2   K
M?0  &               @ %^(P  <V%V82TR,#(R,3$P,WAE>#DY7S$N:'1M
64$L%!@     %  4 30$  !(V      $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
